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Since their discovery, fullerenes and fullerene derivatives have been the subject of 
intense research because of their unique properties and potential applications. The 
combination of a network of conjugated double bonds with high electron affinity makes 
them good electron acceptors, so that, despite being described commonly as antioxidants 
in the biological literature, they may act mechanistically as oxidants. Because of their 
ability to accept electrons, fullerenes can quench reactive oxygen species (ROS), 
particularly free radicals, by accepting their unpaired electron. Overproduction of ROS 
interferes with cell signaling and apoptosis, as well as causing generalized damage to 
biomolecules, through their interaction with lipids, DNA and proteins, thereby 
contributing to chronic diseases. The pro-inflammatory transcription factor NF-κB is 
known to be activated by ROS; modulation of NF-κB signaling is well established as a 
way to control inflammatory immune responses. 
Although there are numerous studies on the biological roles of fullerenes, their 
mechanism of action is poorly understood. The main focus of this research is to clarify 
redox properties and bioactivity of fullerene derivatives, including their fundamental 
redox properties, their interaction with NF-κB and their biocompatibility involving the 
possibility of ROS generation vs. elimination by free radical scavenging. Different C60 
and C70 fullerene derivatives used in these studies include hydroxylated fullerenes 
(C60OHx and C70OHx), carboxyfullerene (C3), amphiphilic liposomal malonylfullerene 
(ALM), fullerene-tetraglycolate TGA and TTA, which were studied in comparison to 
common antioxidants such as ascorbic acid and N-acetyl cysteine. 
The results from the ferric reducing antioxidant power (FRAP) assay demonstrate 
that fullerenes are very poor reducing agents, whereas the results of electro-paramagnetic 
resonance spectroscopy (EPR) confirmed their radical scavenging properties vs. 
superoxide ion.  Taken together, the results of both studies (FRAP and EPR) emphasize 
the need to distinguish between antioxidant and antiradical properties of fullerenes, as the 
latter can occur via oxidation of free radical species.  
Regarding their potential future use in clinical applications, an important finding 
is that hydroxy and carboxy fullerene derivatives exposed to ambient conditions in living 
cells neither produce ROS nor cause any cytotoxicity at nanomolar to micromolar 
concentrations, as shown using proliferation assays and redox sensitive fluorescent dyes. 
On the other hand, TTA and C60OHx fullerenes were found to have a distinct effect on 
mitochondrial function of cells, implying their interference with proton transfer process 
of mitochondrial membrane. However, this effect is apparently not sufficient to decrease 
cell viability. 
The activity of fullerenes as potential anti-inflammatory drugs was investigated 
using several cell-based assays involving an NF-κB reporter gene assay, coupled with 
visualization of nuclear translocation of exogenous (transfected) NF-κB, achieved via a 
construct with the NF-κB p65 gene fused to green fluorescent protein. The fullerene 
derivatives C3 and C60OHx were found to be effective inhibitors of NF-κB driven gene 
expression at micromolar concentrations.  However, unlike some antioxidants such as α-
lipoic acid, they did not inhibit PMA-induced nuclear translocation of exogenous NF-κB 
even at high concentration (40 µM). Along with western blot analysis, this result strongly 
suggests that fullerene derivatives block NF-κB signaling downstream of the cytosolic 
activation pathway (the site of action of many antioxidants), possibly inhibiting NF-κB 
activation at a step penultimate to DNA binding in the nucleus (e.g., by interfering with 
the mandatory reduction of NF-κB by thioredoxin). 
These studies suggest that the molecular basis of action of water soluble 
fullerenes has both similarities and differences to typical antioxidants. Like many 
antioxidants, they are active as NF-κB inhibitors, suggesting a potential role as novel 
anti-inflammatory agents, as they have low overall toxicity. However, they have a 
distinct mechanism of action, such as scavenging free radicals by oxidation, and lack 
activity as direct reducing agents.   
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CHAPTER I 
INTRODUCTION 
This dissertation is focused on the investigation of redox properties of water 
soluble fullerene derivatives, and the assessment of their effect on NF-κB as an important 
transcription factor. This chapter will provide some background for the history of 
fullerenes, their recorded properties and biological activities, typical activities and 
interaction with macromolecules.  
An Overview of Fullerene Discovery, Properties and Applications 
Fullerenes have emerged as one of the most prominent and widely investigated 
classes of nanomaterials. Before their discovery, two main carbon allotropes were known 
to exist: diamond and graphite, but because of the effort of researchers from US and 
Europe [4], fullerenes were discovered in 1985 to present a new molecular form of 
carbon. 
Fullerenes were  later discovered in soot generated from laser ablation of graphite by a 
method developed for their mass production at Rice University [5].  Among the various 
fullerenes that can be formed with varying number of carbon atoms, such as C28, C36, 
C70, C76, C78 and C82 [6, 7],   С60 was observed to be by far the most abundant of these. 
To explain the stability of this molecule, the research team of Harold W. Kroto, Robert F. 
Curl and Richard E. Smalley proposed a highly symmetrical structure of a close sphere 
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cage of sixty carbon atoms, which is considered to be three-dimensional analogue of 
benzene, however it is made entirely of carbon atoms arranged in a truncated icosahedron 
geometry [8] (Figure 1 .A) resembling that of a soccer ball, and lacking in aromaticity. 
This landmark discovery was awarded the Nobel Prize in Chemistry in 1996. C60 was 
given the name buckminsterfullerene, because its structure resembles the geodesic dome 
design of R. Buckminster Fuller. In addition to C60, C70 has been the focus of extensive 
research. The C70 structure (Figure 1. B) is characterized by two reactive poles which 
allow for attachment of lipophilic, hydrophilic, or other functional groups, whereas the 
C70 equatorial region is relatively inert. The polar region has comparatively high 
reactivity due to the significant orbital overlap of its lowest unoccupied molecular orbital 
(LUMO) and highest occupied molecular orbital (HOMO) that is expected for sites of 
maximum radical reactivity. Because of these structural features, C70 molecules provide a 
novel platform for the preparation of various novel compounds, such as amphiphilic 
fullerenes [9]. 
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Figure 1. The unique structure of C60 and C70 molecules. A. A highly symmetrical 3D 
structure of icosahedral shape, C60 is made entirely of carbon atoms arranged in 12 
pentagons and 20 hexagons; every carbon is bound to three other atoms, all in a state of 
sp2 hybridization. The conjugated double bonds are located at C5–C6 bonds (at the edge 
of hexagons). B. A less symmetrical structure, C70 is composed of 12 pentagons and 25 
hexagons. 
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Fullerene chemistry, involving functional derivatization of various kinds, has 
been most extensively developed in the case of C60, together with a less extensive body 
of work on C70. At present most of the published papers described the chemical and 
physical properties of fullerenes C60 and C70, with much less available on the chemistry 
on the higher fullerenes. The intensive investigation that has been done on the chemistry 
of C60 fullerenes over the last several decades shows the rich variety of reactivity of this 
compound and its derivatives. Despite the wealth of such information, given that it takes 
about 250 hours of work to produce just 1 mg of many of these molecules [10], much 
remains to be learned about their activities in biological systems. 
Although fullerenes were first synthesized in the laboratory, they are produced 
naturally as a result of high energy events such as lightning strikes and have been found 
in meteorites and geological samples [11, 12], as well as occurring naturally in soot. 
While nanoparticles, in general are being produced and integrated into different products, 
for example in cosmetics and drugs (Figure 2), there is still a lack of data generated 
regarding their safety and application (Figures 3 & 4). Production of extensive data is the 
first step in the process of issuing guidelines and setting regulations regarding use and 
safety of nanomaterials in general by regulatory agencies. Moreover, the availability of 
more information about those molecules will definitely enhance the marketing and 
commercialization of nano products in general.
4 
Figure 2. The two graphs are based on Espacenet database, show the estimated percentages of NANO-related 
patents of the top 10 COSMETIC (A) and PHARMACEUTICAL (B) companies of the world in 2009 [1, 2]. 
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Figure 3. The estimated number of publications of carbon nanomaterials from 2001 to 
2010. Science Citation Index Expanded/Web of Science [13]. 
Figure 4. The estimated number of publications in FULLERENES in leading countries 
from 2001 to 2010. Source: Science citation index [13].
6 
In spite of the production of workable quantities of fullerenes, their application is 
restricted, particularly in nanomedicine, due to their poor solubility in water. 
Underivatized C60, also known as pristine C60, is a hydrophobic molecule that is most 
easily dissolved in organic solvents. Some procedures can be used to enhance their 
dispersion in aqueous suspension, such as long term stirring in water [14, 15] and 
incorporation into water soluble supramolecular structures such as cyclodextrin [16]. In 
addition to that, the covalent attachment of various polar groups (e.g., –OH, NH2, –
COOH) to fullerene cage results in the formation of functionalized fullerene molecules; 
this procedure, known as exohedral functionalization, allows water to establish bonds 
with hydrophilic addends of fullerene [17-19], enhancing the solubility. 
Research in the field of water soluble C60 fullerene derivatives has increased 
dramatically and many distinguishable biological properties of water soluble fullerenes 
have been exhibited so far including; neuroprotection [20, 21], antiviral activity [22-24], 
antimicrobial activity [25], antiapoptotic activity [26], DNA photocleavage [27] , drug 
delivery [17, 28], magnetic resonance imaging MRI [29]  and contrast agents [30, 31].  
Fullerenol, a polyhydroxylated C60 derivative, was the first water soluble 
fullerenes to be successfully synthesized, in 1992 [32, 33] (Figure 5). Fullerenol (C60-
OHx)  can function as a free-radical scavenger [34], a neuroprotective agent [20] and an 
antiproliferative agent for vascular smooth muscle cells [26].   A fullerene-carboxylic 
acid derivative, C3 (Figure 5), was found to play a role as a neuroprotective agent [21]. 
The  biological functions of the soluble fullerenes have commonly been attributed to their 
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antioxidant properties [34]. However, the reality is more complex, as will be shown later 
in this Dissertation. 
Figure 5. The tris malonyl C60 compound known as C3 (left); the three malonyl groups 
are attached to fullerene compound through [6,6] bonds, and the hydroxylated fullerene 
C60[OH]22 (right). 
The unique electrochemical features of water soluble fullerenes allow them to 
quench reactive oxygen species (ROS) [21], which have been implicated in aging and 
various degenerative diseases, such as diabetes, neurological and cardiovascular diseases 
and cancer [35-38]. 
Role of Free Radicals and Antioxidants 
A free radical can be defined as any molecule or atom with unpaired electrons, 
e.g. as a result of losing one electron from the outer shell, causing it to become relatively 
unstable and highly react with other molecules, from which it can extract an electron in 
order to stabilize its own electron configuration. Free radicals form as metabolic 
intermediates through many different biochemical reactions. However, the 
8 
overproduction or uncontrolled generation of free radicals resulting from metabolic 
dysfunction can cause damage to many biological macromolecules [39]. Free radicals are 
distinguished as highly reactive molecules that explain their toxicological activities, 
examples; superoxides (O2•-) and hydroxyl radicals (•OH) (Figure 6).   
Figure 6. Lewis electron configuration of Oxygen (A), Superoxide anion (B), Hydrogen 
peroxide (C), Hydroxide ion (D) and Hydroxyl radical (E). The difference between 
radicals and the non-radical oxygen species is in the unpaired electron; therefore of the 
molecules shown, superoxide and hydroxyl radicals are the only radical species. The 
unpaired electron is shown in blue.  
The mechanisms underlying aging have yet to be fully elucidated, and the 
emergence of every new aging theory makes it even harder for researchers to recognize 
the entire mechanisms of aging due to the multidisciplinary perspectives involved. One of 
the earliest and most well-known theories of aging, called the free radical theory of aging 
(FRTA), postulates that accumulation of damage to macromolecules caused by free 
radicals causes aging and ultimately death as a consequence [40]. However other data 
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support the evolution of the hyperfunction theory placed by Blagosklonny M. [41]; this 
theory emphasis that aging is not the only factor contributing to death through molecular 
damage and the real cause of aging is hyperfunction, especially excess biosynthesis. This 
hypertrophy is driven by cellular signaling networks that control growth (and thereby, 
reproduction) including insulin, insulin-like growth factor 1 (IGF-1), and in particular, 
the target of rapamycin (TOR) kinase pathways [41]. Furthermore, several biological 
clocks were found to be associated with aging such as telomere length and DNA 
methylation level. 
Since the advent of genetic technologies such as gene knockout organisms, 
various studies have been done to attempt to extend or modify lifespans involving 
genomic mutation or RNA interference for the inhibition of mitochondrial proteins 
expression [42-44]. Surprisingly, it was found that normal to increased oxidative damage 
as a result of superoxide dismutase gene knockouts failed to decrease the lifespan of the 
mutants, as would be predicted by the FRTA. Moreover, it was found that elevated levels 
of superoxides contributed to remarkable longevity of both C. elegans wild type and 
mitochondrial respiratory mutants [45, 46]. Therefore it was concluded that molecular 
damage accumulation due to ROS is not the primary cause of aging. 
While life extension studies have been directed at slowing down the biological 
process to extend the average lifespan [47], it is not well understood if aging occurs in 
parts, for instance, Is it the aging of molecules? organelles? cells or tissues? or the entire 
organism? Scientific data collected so far do not resolve the mystery of aging. This bring 
up the question, Is aging curable?  Is there really a treatment? And if yes, Does the 
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treatment stop the whole process of aging? Or does it only deal with one aspect of it? 
Despite the claims of some drug companies, a real anti–aging drug has not yet been 
realized. 
The FRTA posits that the main players in the process of aging are the free radicals 
or oxidation inducing molecules, i.e. reactive oxygen species (ROS). Any type of 
interference with mitochondrial function affects the mitochondrial production of ROS, 
considering mitochondria as the main site of ROS. ROS in turn interfere with various 
cellular processes, causing oxidative damage that impacts aging (Figure 7). 
ROS have clearly detected roles in interference with cell signaling and apoptosis 
through their interaction with lipids, DNA and proteins [48] resulting in a cellular death, 
Moreover, reaction of macromolecules (lipids, sugars, proteins, and DNA) with ROS 
generates by products that are sometimes more dangerous than the initial ROS [49]. 
Therefore an increase in ROS and the simultaneous decrease in antioxidant mechanisms 
can shift the reduction-oxidant balance toward the oxidation state. 
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Figure 7. A representative diagram of cellular sources and pathways of ROS. 
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Superoxide anion results from normal cellular metabolism and physiological process or from exposure to environmental 
stimulus such as light and smoke. Cellular sources of superoxides, A. NADPH oxidase enzymes, B. Microsomes and 
Peroxisomes, the later produce H2O2 by the function of enzymes such as amino acid oxidase enzymes. C. Xanthine system 
(xanthine oxidases XO catalyze the reaction of hypoxanthine to xanthine forming superoxide anion and xanthine to uric acid to 
form hydrogen peroxide). D. Mitochondria as the main source of reactive oxygen species through the electron transport chain 
(ETC) as well as Cytochrome P450, electron (e-) transfer from NADH and FADH2 through complexes I and II, respectively, 
and then to complex III. Cytochrome c transfers electrons from complex III to complex IV, which reduces O2 to form H2O. 
Leaking of electrons from complexes I and III generates superoxide. Moreover, electrons are substracted from cytochrome c to 
produce O2. Via the ROS redox pathway, superoxide is removed by the dismutation reaction of superoxide dismutases, 
cytoplasmic Cu/Zn superoxide dismutase (SOD-1) and mitochondrial Mn superoxide dismutase (SOD-2) SOD2 in the matrix 
to generate hydrogen peroxide. Under stress conditions, superoxides release iron from iron containing enzymes, where ferric 
ion is reduced to ferrous (Haber-Weiss reaction) as a first step, the second step is the generation of hydroxyl radical (•OH) by 
the Fenton reaction. H2O2 is reduced to H2O by glutathione peroxidase (GPX) using glutathione GSH resulting in an oxidized 
glutathione (GSSG) which is reduced back to GSH by glutathione reductase. H2O2 is a toxic molecule that has been associated 
with tissue damage in cancer and inflammatory disorderes [50]. 
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Under normal conditions, ROS levels are counteracted by antioxidant system, 
which is classified into enzymatic antioxidant defense such as superoxide dismutase (SOD), 
glutathione peroxidase (GPx), catalase, thioredoxin reductase (Trx-Trx)  [51-54] (Figure 7) 
and the non-enzymatic small molecule dietary antioxidants such as thioredoxin (Trx), 
glutathione, carotenoids, vitamins E (α-tocopherol) and vitamin C (ascorbic acid) [55-
57]. Figure 8 shows structures of some antioxidants like N-acetyl cysteine (NAC) and 
Lipoic acid (LA). 
Antioxidants preferably interact with compounds containing functional groups 
with electron-rich double bonds such as sulfides and phenols that are easily oxidized. The 
mechanism behind the activity of common antioxidants against free radicals is well 
known, one mechanism involves the reduction of radicals (R.) by the thiol group of sulfur 
containing antioxidants like N-acetyl cysteine (NAC) and Lipoic acid (LA) [58], 
 R.  +  NACSH RH + NACS     (RH= reduced radical) 
The second mechanism is the donation of the hydrogen atom from phenolic group of non 
thiol antioxidants, such as ascorbic acid (AscH2) to reduce radical anions, via electron 
transfer process [59]. 
 R. + AscH RH + Asc . -  
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Along with the capability to remove radicals, thiol or enzymatic antioxidants have 
protective role against protein oxidation, the presence of cysteine residues in their active 
reduce the oxidized protein thiols contributing to an intracellular redox hemostasis. 
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Figure 8. Structure of common non enzymatic antioxidants. Ascorbic Acid, N- acetyl 
cysteine, NAC and Lipoic Acid. 
Ascorbic Acid, C6H8O6, turns into 
ascorbate anion AscH- at pH 7.4 
N-acetyl cysteine, NAC, C5H9NO3S 
Lipoic Acid, reduced form (Dihydrolipoic acid), C8H14O2S2 
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Oxidized proteins are more susceptible to proteolysis and an increase in oxidized 
proteins attacked by ROS might affect certain biochemical functions [60] and decrease 
cell viability (Figure 9). The cysteine thiol groups involved in protein structures are part 
of redox signaling in cells  [61] (Figure 9). The disulfide bridge RS-SR (oxidized status) 
formed as a result of redox reaction of cells leads to stabilization of protein structure.  
Cysteine thiol group can act as a nucleophilic site in many critical sites of the proteins 
such as active sites; typically, thiol groups of cysteine side chains are the most potent 
nucleophile of all amino acids. Under the influence of pathophysiological stimuli, thiol 
RSH is oxidized by hydrogen peroxide to sulfenic acid RS-OH. Cysteine groups on 
glutathione and thioredoxin are critical for their action as peptide/protein reducing agents 
and redox modulators. 
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Figure 9. A representative diagram of cellular stimulation by certain factors (ROS, UV 
and cytokines such as TNFα). The stimulation of cells results in the activation of NIK 
(NF-κB inducing kinases) and (MAP) mitogen-activated protein (MAP) kinases mediated 
by c-Jun amino-terminal kinases (JNK) and p38 which are activated by TRAF2 leading 
to the subsequent activation of transcription factors. This diagram also shows the 
interference of ROS with protein signaling pathways by oxidization of sulfhydryl groups 
on protein cysteine residues. Changes in protein structure (Oxidation of thiol groups) 
leads to the dysregulation of several signaling cascades such as growth factor kinase-, 
src/Abl kinase-, mitogen-activated protein kinase (MAPK) which activates several redox-
regulated transcription factors such as activator protein 1 (AP-1), NF-κB, p53, hypoxia-
inducible factor 1 (HIF-1) and nuclear factor AT (NFAT)]. These factors control gene 
expression involved in DNA repair, cell growth and differentiation and the immune 
system.
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Mechanism of Action of Fullerenes as Free Radical Scavengers 
It was not until early 1990s that C60 and C70 were found to react with free radicals 
[62, 63]  and the fullerene core characterized as being a free radical sponge. The details 
of the mechanism underlying the protective function of fullerene derivatives remain 
elusive. The delocalized π double bonds increase the reactivity of C60 and allow them to 
react in different ways.  Free radicals can react with C60 molecules by direct binding 
through the delocalized π electrons, via addition to the carbon-carbon double bond [62]. 
Andrievsky [64] theoretically estimated that a total of 60 radicals can bind to a single 
pristine C60, based on the fact that one carbon double bond can scavenge two radicals 
(Figure 10).   However, the number of radicals able to react with modified fullerene 
derivatives having fewer double bonds than pristine C60 could be much less,depending on 
the number and position of the attached chemical groups, and how the latter modify the 
electronic structure of the molecule.  
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Figure 10. Simplified representation of the net reaction of OH radical with C60. C60 core 
acts as sponge and scavenge free radical by direct binding. 
Instead of direct binding of free radicals to C60 double bonds, an alternative 
mechanism of superoxide dismutation was suggested for the SOD-mimetic C3 carboxylic 
fullerene [65, 66], although the ability of C3 to scavenge superooxides was found to be 
lower than SOD1 and SOD2 (superoxide dismutastion enzymes). C3 acts as nucleophilic 
with super delocalizability and was found to fom a complex with O2•-. In fact Liu [67] 
claimed to be the first to detect the catalytic dismutation activity through O2•- oxidation 
within an electron transfer process.   
We hypothesized as a result of using FRAP assay (ferric reducing/antioxidant 
power) and an electron paramagnetic resonance (EPR) spin trapping technique 
(Rawashdeh et al. 2014) that the existence of conjugated double bonds makes fullerene 
derivatives a good electron acceptor not donors therefore they act as oxidants rather than 
reductants. Fullerenes are involved in redox reaction in the cells. Fullerenes go through a 
reduction-oxidation chain, where the electron transfers from superoxide to fullerene in 
the first place to result in oxidizing the superoxide into oxygen and reducing fullerene 
into fullerene anion. The generated fullerene anion donates the extra electron to another 
superoxide resulting in its being reduced to peroxide ion. This net dismutation of 
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superoxide by C3, and related results for other fullerene derivatives, has led researchers 
to label fullerene derivatives as biological antioxidants.  However, they appear to work, at 
least in part, by an oxidative mechanism: 
F   +   O2·−    →   F·−   +   O2      (oxidation) 
F·−   +   O2·−    →   F   +   O2−2       (reduction) 
Based on these results (detailed in chapter 2), water soluble fullerenes can be 
considered to have redox cycles, analogous to those seen in the redox cycles of other 
biological antioxidants like glutathione, thioredoxin (Trx) and vitamin C.   
The biological activity of fullerene derivatives is due to their unique properties 
such as; their large surface area: mass ratio, which makes them important as catalysts in 
chemical reactions; therefore, fullerene derivatives could scavenge intracellular ROS and 
regulate NF-kappaB activation. 
NF-KappaB Signal Transduction Pathway as a Target of Free Radicals 
Nuclear factor kappaB (NF-κB) is one critical protein that might be targeted by 
ROS where the reactive oxygen intermediates have been proposed to be involved in 
activation of NF-κB [68-71]. It has been proposed that the initial response to inducers is 
the production of superoxide anion followed by the generation of H2O2 [70]. The 
activation of NF-κB signal transduction pathway (a set of protein reactions that activate 
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NF-κB, see Figure 11) by ROS mediates pathological disorders such as inflammatory 
diseases; rheumatoid arthritis and lung diseases [72].  
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 Figure 11. Canonical NF-κB regulation pathway of the heterodimer RelA/P65. Stimuli 
(such as TNFα, PMA, ROS and smoke) induce the phosphorylation of IKB at 
Ser32/Ser36 through TRAF2/6–NIK kinase pathway. Phosphorylated IKB undergoes 
proteosomal degradation releasing NF-κB and allowing it to translocate into the 
nucleus. Trx-1 reduces NF-κB in nucleus and NADPH reduces the oxidized Trx. NIK 
is NF-κB inducing kinase.  (  ) is the nuclear localization signal (NLS) that guides 
NF-κB translocation into the nucleus.            represents an oxidized Trx-1. Trx-1 
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This study was inspired by the extensive research that is widely done showing the 
bio-protective and anti-inflammatory roles of water soluble C60 fullerenes. The aim of 
this research is to study electrochemical and redox properties of water soluble fullerene 
derivatives; C60OHx, C3, TGA, TTA and amphiphilic liposomal malonylfullerene ALM 
and correlate their structure with possible mechanism of interaction with NF-κB and 
ROS. Evaluation of antioxidant and free radical scavengers properties were done by 
FRAP and EPR respectively (Chapter 2). Electron paramagnetic resonance (EPR) 
spectroscopy is a magnetic resonance technique used to detect free radicals. 
The activity of NF-κB pathway in the presence of fullerenes was tested by using 
two plasmids separately, one that has multiple kB sites driving expression of the B-
galactosidase reporter gene and the other having p65 tagged to GFP for fluorescence 
intracellular localization studies (Chapter 3). Fullerene derivatives were kindly provided 
by Luna nanoWorks (Luna Innovations Inc. VA) as suspensions in ionic solution 
(phosphate buffer saline, PBS). To our knowledge this study is one of the first to directly 
study the effects of water soluble fullerenes on NF-κB driven gene expression, and the 
underlying mechanisms. 
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CHAPTER II 
THE FULLERENE PARADOX: BIOLOGICAL ANTIOXIDANTS WITH LOW 
INHERENT REDUCING ABILITY 
Abstract 
Fullerene derivatives have been studied for a wide variety of applications in the 
physical and life sciences. Their unique combination of spheroidal structure with an 
extensive conjugated bond network enables electron delocalization and mobility, making 
them highly suitable for electron transfer applications. This property underlies many 
applications and activities of fullerene derivatives, e.g., as acceptors moieties for 
photovoltaics. This is consistent with their high electron affinity, which should make 
them potential oxidizing agents. Paradoxically, in biological applications, fullerenes have 
an established reputation as antioxidants, which appears to be based largely upon their 
ability to scavenge free radicals. We tested 6 different fullerene analogs for their ability 
to reduce ferric to ferrous iron, a standard test for reducing power (FRAP assay); at 
concentrations up to 10μM, none had significant activity, as compared to N-
acetylcysteine and vitamin C as positive controls. In line with previous reports, we found 
that the tris-malonate fullerene derivative C3 was able to scavenge superoxide, as 
assessed by EPR spectroscopy. Because our results confirm that fullerenes lack direct 
reducing ability, we conclude that native fullerenes scavenge superoxide radicals initially
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by oxidizing them, accepting an electron from superoxide to generate molecular oxygen, 
along with a reduced fullerene molecule having an extra electron (F·−). The latter, a 
fullerene anion, could function as a direct reducing agent by donating its electron, 
contributing to the reported antioxidant activities of fullerene derivatives. Finally, we 
propose a fullerene redox cycle analogous to those of other biological antioxidants like 
glutathione, thioredoxin and vitamin C. 
Introduction 
 Fullerenes are now routinely produced in useful quantities and studied for 
engineering applications such as photovoltaics and, increasingly, for biomedical uses. 
However the later application is restricted by the poor solubility of native fullerenes in 
water. Pristine C60 is a hydrophobic molecule that is best dissolved in organic solvents. 
Some procedures can be used to enhance their dispersion in aqueous suspension, such as 
the addition of surfactant [15] long term stirring in water [14] and incorporation into 
water soluble supramolecular structures such as cyclodextrins [16].  In addition, 
exohedral chemical functionalization, which involves the covalent attachment of various 
functional groups (e.g., –OH, NH2, –COOH) to the fullerene cage, results in the 
formation of ‘‘functionalized’’ fullerene molecules that are able to establish bonds with 
water molecules via hydrophilic extensions [22-24, 73].  
Research in the field of water soluble fullerene derivatives (e.g. trismalonic acid 
C60, known as C3, Table 1) [15] has increased dramatically and many distinguishable 
biological properties of fullerenes have been exhibited so far, including: neuroprotection 
[21], protection against excitotoxic stimuli [20], antiapoptotic activity [20, 26], antiviral 
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activity [22-24],  anti-aging effects [74], anti-inflammatory activity [9, 75, 76] and 
protection against oxidative stress induced by UV radiation [77]  iron [78]  or peroxides 
[77, 79]. Indeed, most of these biological activities of fullerene derivatives have been 
thought to be due to their antioxidant or free radical scavenging activity. Many of these 
studies hypothesize that antioxidant activity mediates functional biological responses, 
based upon either the demonstration of free radical scavenging ability, or an endpoint 
such as a decrease in lipid peroxidation products, or increased cell viability.  
Biological antioxidants are important for living systems because they function as 
a defense mechanism against reactive oxygen species (ROS), the most reactive of which 
are free radicals such as hydroxyl radical (·OH) and superoxide (O2·−). ROS can be 
produced during normal cellular processes such as oxidative metabolism, or from 
exposure to environmental stimuli such as light and smoke. Under normal condition ROS 
levels are kept in check via natural antioxidants, which can be peptides (e.g. glutathione), 
proteins (e.g. thioredoxins, glutathione peroxidases and superoxide dismutases) [53, 80-
82], or small molecules (dietary antioxidants) including α-lipoic acid, vitamins E, C and 
carotenoids [55, 57, 83]. ROS have well established roles in interference with processes 
such as cell signaling and apoptosis through their interaction with lipids, DNA and 
proteins, which if unchecked by antioxidant defenses can result in cell death and organ 
failure [84]. An increase in ROS with a concomitant decrease in antioxidant mechanisms 
can shift the oxidation-reduction balance toward the oxidation state. Oxidized proteins 
are more susceptible to proteolysis and an increase in oxidized proteins attacked by ROS 
can affect various biochemical functions. Thus, the possibility that fullerene derivatives 
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can serve as biological antioxidants or free radical scavengers is of considerable 
importance for the development of novel therapeutic entities.  
A case can be made that most of the applications of fullerenes, both physical and 
biological, are based primarily upon their electronic properties, and to a lesser extent 
upon their shape and other aspects. Their unique combination of a spheroidal structure 
with an extensive conjugated bond network enables electron mobility and partial 
delocalization, making them highly suitable for electron transfer applications. Physical 
and computational data suggest that fullerenes are much better electron acceptors than 
electron donors. The electron affinity of C60 is quite high (2.65 eV) [85], approaching 
that of the halogens (3-3.6 eV), with energy being released on binding an electron; in 
contrast, an even greater amount of energy must be expended to remove an electron from 
C60 (first ionization energy ≈ 7.7 eV) [86]. Hence, fullerenes react primarily as 
electrophiles, so that much of the chemical functionalization of fullerenes is achieved via 
nucleophilic additions to the carbon cage, using various reagents. Furthermore, native C60 
has 60 pi electrons, so that 12 additional electrons would be needed to form a closed shell 
configuration of 72 electrons, as required for spherical aromaticity by the 2(N+1)2 rule 
[87]; this state is attainable in alkali fullerides such as K+12C6012− [88]. 
This propensity to accept electrons underlies many applications and activities of 
fullerene derivatives, e.g., their use as acceptors moieties for photovoltaics [89]. 
Paradoxically, the biological literature is full of references to fullerenes as antioxidants, 
although the evidence cited is typically of roles as free radical scavengers. Yet it is rarely 
if ever noted in such contexts that their avidity for electrons would make it more likely 
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for a fullerene derivative to be an oxidizing agent than an antioxidant, in the strict 
chemical sense of an antioxidant as a molecule with reducing ability, i.e., an electron 
donor. We will explore the hypothesis that the apparent antioxidant and radical 
scavenging abilities of some fullerenes may arise not from any inherent activity as 
reducing agents (electron donors), but from their ability to oxidize free radicals (i.e., 
accept their unpaired electrons), so that they are not direct acting reducing agents. 
However, oxidation of a free radical or other species by a fullerene can generate an 
anionic fullerene species (F·−), which does have the capacity to act as a reducing agent by 
giving up its electron(s).  
The majority of the reports like those cited above of the “beneficial” effects of 
fullerenes, involving free radical scavenging and protection against oxidative challenge, 
have used fullerenes functionalized with hydroxyl or carboxylate-bearing groups, like 
those shown in Table 1. In contrast, reports that fullerenes can cause oxidative stress and 
free radical damage [90-93] have generally involved studies of native (unfunctionalized) 
C60 or C70, which are also much less soluble than the functionalized oxygenated 
fullerenes. This hydrophobicity may target them to cell membranes, which are highly 
susceptible to oxidant damage. However, it has also been reported that C60 incorporated 
in a water-soluble liposomal preparation showed both free radical scavenging and 
cytoprotective abilities. These results are hard to reconcile, unless it is simply the 
solubilization of fullerenes (either by functionalization, and/or by physical means such as 
liposomes) [94] that promotes their anti-radical anti-oxidative stress profile, and 
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somehow limits their ability to induce oxidative stress via their inherent potential as 
oxidizing agents (due to the avidity of the fullerene core for electrons).  
To shed light on the question of whether soluble fullerene derivatives are 
functioning as biological antioxidants due to an inherent ability to act as reducing agents, 
or indirectly via an anti-radical activity that could involve oxidation of free radicals, we 
tested the ability of a panel of soluble fullerenes (shown in Table 1) to act as direct 
reducing agents.  
For this purpose, we used the FRAP assay (originally the ferric reducing ability 
of plasma assay [95] also known as ferric reducing antioxidant power), which is an 
electron transfer-based assay that is commonly used to test the antioxidant capacity of 
foods, fruit extracts and dietary supplements. FRAP has been reported to be the most 
efficient assay in terms of reproducibility, simplicity and rapid performance among 
different antioxidant assays including ORAC (the oxygen radical absorption capacity), 
ABTS (2,2-azinobis (3-ethyl-benzothiazoline-6-sulfonic acid) and DPPH (2,2-diphenyl-
1-picrylhydrazyl) [96]. Thus it should be an appropriate technique for the assessment of 
fullerene antioxidant activity. In the FRAP assay, as shown in the equation below, 
antioxidant (reducing) activity is assessed via the reduction of Fe+3 (ferric) ion to Fe+2 
(ferrous), which at low pH results in the formation of a ferrous-tripyridyltriazine (TPTZ) 
complex with an intense blue color, having a peak absorption at λ= 593nm [95]. 
Fe+3(TPTZ)2   (colorless)  +   e−  →   Fe+2 (TPTZ)2  (blue) 
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Note that in the general formulation shown above, the electron is donated by the 
reducing agent (antioxidant) being tested. The ability to reduce Fe+3 to Fe+2 would be 
expected for a typical water-soluble antioxidant [96].  
For assessing the free radical scavenging activity of water soluble fullerenes, 
electropara-magnetic resonance (EPR) spectroscopy has been used in various studies, due 
to its ability to detect free radical species (see appendix A. for principles of EPR 
spectroscopy). Because the soluble carboxyfullerene C3 has been reported to be a 
functional mimic of superoxide dismutase [65, 67, 74] we focused our EPR studies on 
that compound, to confirm its ability to scavenge superoxide.  
In the current study, we will show that, as expected from the fundamental 
electronic properties of fullerenes reviewed above, a set of typical water soluble 
fullerenes (Table 1) including C3 and C60OHx show negligible reducing ability in the 
FRAP assay. Thus, the mechanism underlying their documented free radical scavenging 
properties (which we confirm for C3) requires a more nuanced explanation than their 
labeling as “antioxidants” would suggest. 
31 
Table 1. Structures of various water soluble fullerene derivatives 
Name Chemical structure Molecular 
weight 
g/mol 
C70-TTA  
C112 H68 O28 
1860 
C70-TGA  
C84 H12 O16 
1276 
C60OHx  
X=~22-29  
Hydroxylated 
fullerene 
(Fullerenol) 
~1146a 
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C3  
Trismalonic acid 
C60  
1027 
C70OHx  
X=~20 
~1181a 
ALM 
Amphiphilic 
liposomal 
malonylfullerene 
1498 
aThe molecular weight is approximate as the exact number of OH groups is variable (see 
appendix A, p.134)
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Materials and Methods  
Fullerene samples. Fullerene derivatives were kindly provided by Luna nanoWorks 
(Luna Innovations Inc., Danville, VA) as 1 mg/ml solutions or suspensions in ionic 
solution (Phosphate buffer saline, PBS).  
FRAP Assay. The FRAP assay was performed according to Benzie and Strain [95] with 
some modifications. This involves 3 stock solutions, including a 300 mM acetate buffer, 
pH 3.6 (3.1 g sodium acetate.3H2O and 16 ml glacial acetic acid in 1 liter distilled water), 
which was stored for later use. Fresh solutions of a) 20 mM Ferric chloride and b) 10 mM 
2,4,6-tripyridyl-s-triazine (TPTZ, 0.031 g in 10 ml of 40 mM HCL dissolved at 50 °C on 
a water bath) were prepared at each use. For a single microplate, an adequate volume of 
the fresh working solution (FRAP reagent) is prepared by mixing 10 ml acetate buffer 
with 1ml TPTZ solution and 1ml FeCl3 solution. Assays were conducted in 96 well 
microplates; in individual wells, 11 μl of sample was tested in a total reaction volume of 
111 μl (100 μl FRAP reagent + 11 μl sample or PBS for blanks). Absorbance 
measurements were taken on a BioTek Synergy MX plate reader using Gen5 software 
version 1.09.8 (BioTek Instruments, Inc., Highland Park, Winooski, VT).  
Vitamin C and N-acetyl cysteine (NAC) were used as positive controls in the FRAP 
assay. Ferrous sulphate was used as the assay standard. FRAP reagent alone was read as 
background (blank); the average blank absorbance was subtracted from sample 
absorbance values obtained at 593 nm. Because the fullerene solutions have significant 
opacity, particularly at high concentrations, they have baseline absorption across the 
visible spectrum. To correct for this, the blank value was customized for each fullerene 
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dilution by addition of a value corresponding to the absorbance due to the fullerene alone 
at that dilution. The latter contribution was determined by mixing 11 μl of each fullerene 
dilution with 100 μl of distilled water, measuring the absorbance of that solution at 593 
nm and subtracting from it the absorbance of 111 μl of distilled water. The resulting 
number was then added to the blank value for FRAP reagent alone, giving a custom blank 
value for each fullerene at each concentration tested.  
Electron paramagnetic resonance (EPR) spectroscopy. EPR spectroscopy was used to 
monitor changes in superoxide levels in the presence of fullerene derivatives. As most 
radical species are difficult to detect because of their short life span, the spin trapping 
reagent DMPO (5,5-dimethyl-1-pyrolline-N-oxide) is generally used for the detection of 
radicals; this forms a persistent aminoxyl spin-trapped adduct with a longer life-span. In 
the presence of DMPO, the adduct DMPO-·OOH is formed from superoxide; detection of 
this adduct correlates to superoxide levels (Figure 12).  
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Figure 12. Generation and detection of superoxide radical by electron paramagnetic 
resonance (EPR) spectroscopy (after Fig. 1, Togashi et al. [3]). Xanthine oxidase (XO) 
oxidizes xanthine to uric acid and the released electrons react with oxygen molecules 
forming superoxide ions. The spin trapping reagent DMPO (5,5-dimethyl-1-pyrolline-N-
oxide) is used to trap superoxide radicals by forming a DMPO-·OOH adduct. DMPO-
·OOH is unstable and decomposes to DMPO-·OH; both have characteristic EPR signals.
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Superoxide (O2·− ) was generated from the reaction of xanthine/xanthine oxidase 
at a concentration of 0.5 mM and 50 mU/ml respectively and in the presence of 1mM 
diethylenetriaminepentaacetic acid (DETAPAC) and 100 mM DMPO in PBS as the 
control and also in the presence of either 40 or 100 μM of fullerene C3, or 40 μM 
ascorbate (vitamin C), as O2·− scavenging agents (see appendix A, pages;129,130, 131, 
132 & 133). EPR spectroscopy was carried out using a Bruker Instruments EMX 10/12 
EPR spectrometer equipped with a standard cavity (ER4102ST). Collection of EPR 
spectra was initiated approximately 3 minutes after the introduction of xanthine oxidase 
to the sample on ice and transfer to a glass capillary tube with inner diameter of 0.8-0.9 
mm. EPR spectra were collected using the following conditions: temperature 296ºK, 
microwave frequency 9.8GHz, microwave power 20mW, modulation amplitude 1 G and 
modulation frequency 100 kHz. The total scan time for each spectrum was around 6 
minutes. 
Results  
FRAP Assay. All of the fullerene derivatives shown in Table 1 were tested for ability to 
reduce Fe+3 to Fe+2 in the FRAP assay. Of these, TTA, TGA, C3, C70-OHx and C60-OHx 
were tested at final concentrations up to 20 μM (Figure 13); due to limited quantity, ALM 
was tested only up to 5μM, at which its FRAP activity was not significant. It is of interest 
that the absorbance values for ascorbate were approximately double those of the 
equivalent concentrations of ferrous ion, which is consistent with its ability to provide 2 
electrons in becoming fully oxidized to dehydroascorbate, i.e., one molecule of ascorbate 
can reduce 2 Fe+3 ions to Fe+2. In contrast, absorbance readings for NAC are close to 
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those for the equivalent Fe+2 concentrations. FRAP values of all of the fullerenes tested 
were not significantly different from the corresponding blank values, except at the 
highest concentration tested, where the values for TTA, C3 and C60OHx, although quite 
small, were significant at p < 0.05; however, these values are less than 10% of the FRAP 
value for ascorbate at the same concentration (see appendix A. p. 135; for the color 
change as a result of reduction). If real, that would suggest that it would take at least 5 
fullerene molecules to reduce a single Fe+3 ion to Fe+2. It is more likely that the 
absorbance here is an artifact of the opacity of the fullerene solutions at high 
concentrations, which our blank correction protocol cannot perfectly correct for. In any 
case, the results show that, under these assay conditions, the water soluble fullerenes 
tested are at best extremely weak reducing agents.
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Figure 13. FRAP assay results for soluble FULLERENES as compared to typical thiol 
(N-acetyl-cysteine, NAC) and non-thiol (ascorbate) ANTIOXIDANTS used as standards. 
Data are plotted as raw absorbance values after subtracting the blanks (see methods 
section); these values correlate to the amount of ferrous ion generated by reduction of 
Fe+3, which relates to the antioxidant power of the tested compounds. Results shown as 
FS are from the corresponding concentrations of ferrous sulfate, used for calibration. 
Various fullerenes (TTA, TGA, C3, C70-OHx, and C60-OHx) were tested at final 
concentrations up to 20 μM; due to limited quantity, ALM was tested only up to 5μM, at 
which its FRAP activity was not significant. In contrast to the positive controls ascorbate 
and NAC, the near-zero FRAP values of the fullerene derivatives show that they do not 
possess sufficient antioxidant power to reduce ferric ion in this assay. The values are the 
average of three independent experiments, ± S.E.M.
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Electron paramagnetic resonance (EPR) spectroscopy. EPR spectroscopy was used in 
this study to detect the scavenging of superoxide anion radicals by C3 fullerene. Previous 
studies have used various concentrations to demonstrate the scavenging capability of 
water soluble fullerenes. The carboxyfullerene C3, as one of the most extensively studied 
fullerene ROS scavengers, was reported to quench ROS signals at 40μM concentration 
[97]. Based on that result and in an attempt to detect similar activity, 40μM concentration 
was chosen to evaluate the scavenging activity (for EPR spectra at 40μM concentration of 
different fullerene derivatives; see appendix A. pages;129, 130, 131, 132 & 133). Some 
researchers have used higher concentrations of fullerenol and C3 to detect their ROS 
quenching capability; for example, a concentration of 100μM was used in study of Dugan 
et al. to demonstrate ROS quenching of fullerenol [20] and by Yin et al. using 
carboxyfullerene and fullerenol [98]. We used the xanthine/xanthine oxidase system to 
generate superoxide, with DMPO as the spin trapping agent. As shown in Figure 14, the 
superoxide signal was reduced in the presence of C3 fullerene at 40μM, and nearly 
eliminated by C3 at 100μM. However, the ability of fullerenes to quench the superoxide 
signal is less than that of an equivalent concentration of vitamin C, which eliminated the 
superoxide signal at 40μM.
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Figure 14. EPR spectra of DMPO-·OOH (superoxide adduct) generated from 
xanthine/xanthine oxidase in the absence and presence of vitamin C or C3. Asterisks 
point to peaks characteristic of superoxide. Collection of the EPR spectra was initiated 
approximately 3 minutes after the introduction of xanthine oxidase to the samples. The 
top spectrum represents the control (superoxide generated in the absence of any 
scavenging agent). The superoxide EPR signal was decreased in a dose-dependent 
fashion by C3 fullerene at 40 and 100 μM concentrations. The signal was not detectable 
in the presence of 40 μM of vitamin C. 
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Discussion 
The 6 water-soluble fullerenes listed in Table 1 (C60OHx, C3, C70-ALM, C70OHx, 
TTA and TGA) showed very weak ability, if any, to reduce ferric to ferrous iron in the 
FRAP assay (Figure 13). This finding is consistent with the known electrochemical 
properties of the fullerene core reviewed in the Introduction, which suggest it is much 
more likely to function as an electron acceptor, as opposed to an electron donor, making 
it less favorable for fullerene derivatives in general to act as reducing agents.  
Given the extensive body of evidence that many fullerene derivatives, e.g. hydroxylated 
and carboxylated analogs, can act as free radical scavengers in both cell-based and cell-
free systems, which we have confirmed in the present study in the case of the tris-
malonate derivative C3 (Figure 13), our results strongly support the conclusions of Liu et 
al.[67] in regard to the mechanism by which carboxy fullerenes act as mimics of 
superoxide dismutase SOD. As stated by those authors, based on cyclic voltammetry, 
spectrophotometric, and submillisecond mixing UV/Vis stopped flow measurements, for 
the carboxy fullerenes studied, "the higher the reduction potential (ability to be reduced 
by O2·−)  the higher the SOD activity.. the electron transfer from O2·−  to the fullerene 
plays a key role in the overall catalytic dismutation of superoxide"[67] . 
Thus, Liu et al. make a compelling case that carboxy fullerenes that act as SOD 
mimics (including C3 and closely related compounds such as their structure V) do so by 
oxidizing superoxide radicals in the first case, accepting an electron from superoxide to 
generate molecular oxygen, along with a reduced fullerene molecule having an extra 
electron (F·−),  i.e., a fullerene anion:  
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F   +   O2·−    →   F·−   +   O2 
Their results also support the hypothesis that, by donating its extra electron, the 
fullerene anion generated in the first reaction is able to scavenge a second molecule of 
O2·−  by reducing it to peroxide ion, regenerating the original native fullerene in the 
process:  
F·−   +   O2·−    →   F   +   O2−2 
Along with the initial oxidation of O2·−  to O2, this forms a complete dismutation 
cycle in which two molecules of O2·−  are converted to O2 and O2−2  (peroxide) in 
successive steps [67]. Significantly, this scavenging of the second O2·−   by a fullerene 
anion is a genuine reduction, so that, to the extent such fullerene anions are available in 
situ as a result of native fullerene molecules oxidizing radicals like superoxide, they 
would be expected to further contribute to the widely reported free radical scavenging 
and antioxidant activities of fullerene derivatives.  
It is of interest to view these reactions of the native fullerene and fullerene anion 
with superoxide as part of a redox cycle, analogous to those of other biological 
antioxidants like glutathione, thioredoxin (Trx) and vitamin C. In such schemes, the 
redox molecule of interest (e.g. Trx) exists in both oxidized and reduced forms. Figure 
15.A shows such a scheme, in which the native or pristine fullerene is shown with an
asterisk (F*), with the reduced form being the fullerene anion (F·−).   It is notable that, in 
analogous schemes, e.g. for the redox cycling of Trx shown for comparison in Figure 15. 
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B, the position occupied by F* corresponds to the oxidized form of the redox molecule. 
This suggests that, as we have indicated via (Ox) next to the F* species, it is appropriate 
to think of the native fullerene as a (relatively) oxidized form, able to accept electrons as 
it oxidizes O2·− [67] and possibly other ROS that are susceptible to scavenging via 
oxidation. 
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Figure 15. REDOX cycle for A) the reactions of a generic NATIVE fullerene F* and fullerene 
ANION F·− with superoxide, compared to B) an analogous scheme for thioredoxin (Trx), a 
typical thiol reducing agent. In such schemes, the redox molecule of interest exists in both 
oxidized and reduced forms. In A, the native fullerene is indicated with an asterisk (F*), with the 
reduced form, after accepting an electron, being the fullerene anion F·−. Note that the position 
occupied by F* corresponds to the oxidized form of the redox molecule (i.e. TrxS2 in the middle 
left of scheme B). As indicated via (Ox) next to the F* species, this suggests that the native 
fullerene is acting as a (relatively) oxidized form, able to accept electrons as it oxidizes other 
species such as O2·−. In contrast, the resulting fullerene anion F·− is able to act as a direct 
reducing agent by donating its electron, reducing superoxide to peroxide [67] and possibly 
reducing other ROS as well (lower reaction of scheme A). In scheme B (after Holmgren et 
al.[80]), TrxR represents Trx reductase. 
Of course, the scheme shown in Figure 15.A could also be extended to the left, by 
showing the loss of an electron by F* to give an F+ species, via an interaction with a 
sufficiently powerful oxidizing agent; in that case, F* would be the (relatively) reduced 
form in relation to a more oxidized F+ state. However, the point is that given the 
proclivity of the fullerene core to accept electrons rather than donate them, the redox 
scheme shown in Figure 15.A is likely to be the most relevant for an understanding of the 
redox behavior of water-soluble oxy- and carboxy-fullerenes and related derivatives 
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under physiological conditions. So, we conclude that, mechanistically, in living cells a 
native fullerene F* is more likely to be acting in the role of an oxidized form (and as an 
oxidizing agent), in a redox scheme such as 15.A. In this scheme, it is the cognate 
fullerene anion F·− that, as the reduced form, could act as a direct reducing agent. At the 
bottom of Figure 15.A, this is shown reducing O2·−  to peroxide ion, but it could also act 
to directly reduce other ROS, as suggested in the figure.  
One other fascinating physical property of solubilized fullerenes relevant to this 
discussion is that of their color in solution. Martínez et al. [99] have suggested an 
association between the natural pigmentation of certain compounds and the mechanism 
of their antiradical activity, which can be achieved by either donating or accepting 
electrons from the radical species. Their results suggest that the antioxidant vitamins and 
natural products that neutralize free radicals by reduction (by donating electrons to them) 
tend to be colorless or yellow, while the carotenoids that are better electron acceptors, 
and neutralize free radicals by oxidizing them, tend to be red in color. In essence, they 
propose that “red pigments are better electron acceptors than yellow or colorless 
substances” [99].  
This is of interest in regard to the water soluble fullerenes, some of which 
(including C3) tend to be red or reddish brown in solution (Figure 16). C60 itself is known 
for forming purplish or pink solutions in many solvents, and C70 solutions are a deep red. 
Given the data presented here confirming that they are poor reducing agents, and 
evidence that they scavenge superoxide by oxidizing it [67], the water soluble fullerenes 
also appear to align with the trend suggested by Martinez et al. We also find considerable 
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merit in their proposal that the more descriptive term “antiradical” be used instead of 
“antioxidant” to describe radical scavengers that act as electron acceptors, and therefore 
scavenge radicals by oxidizing them.  
Figure 16. Colors of fullerenes in solution. A. Stock solutions of TTA, C3 and TGA (left 
to right), each at 1 mg/ml concentration; all are red or reddish-brown. B. C60 in solution 
in an organic solvent [100]. 
Conclusions 
To our knowledge this study is the first to test the antioxidant properties of 
fullerenes using the FRAP assay, which is a simple way to assess their ability to donate 
electrons. Taken together, our FRAP and EPR spectroscopy results show that these 
compounds are poor reducing agents, yet can be active free radical scavengers. These 
results emphasize the need to distinguish between antioxidant and antiradical activity, at 
least, if one hopes to understand the mechanism of action of the molecular species 
involved, which is critical for rational drug design. The possible need for this distinction 
may well hinge on the definition of antioxidant, which could be stated so as to leave open 
the possibility of an indirect antioxidant action such as free radical scavenging, rather 
than direct reduction of an oxidizable substrate.  
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Consider one of the more formal attempts to define an antioxidant, by Halliwell 
and Gutteridge, as “any substance that, when present at low concentrations compared to 
those of an oxidisable substrate, significantly delays or prevents oxidation of that 
substrate” [101]. Even this definition fails to distinguish between direct and indirect 
effects. Does it apply only when the two species are isolated in solution in a cell free 
system, where a direct reduction is more likely to be required? Or if a molecule blocks 
lipid peroxidation indirectly by scavenging certain ROS by oxidizing them, thereby 
limiting free radical chain reactions that underlie the process, does that fall under the 
definition? Even those eminent authors go on to say that “there may be cases which the 
definition does not include”, giving an example of the sequestering of metal ions by 
plasma protein binding. But they express reluctance to broaden the definition to include 
“any substance that inhibits oxidative damage to a target under the assay conditions being 
used”, as this would open the door to almost everything being either an antioxidant or a 
prooxidant [101].  
So it is unlikely that the current work will induce a change in the use of the term 
“antioxidant” to describe the cellular action of various fullerenes that are not really 
functioning as reducing agents. Fullerenes nonetheless do fall under a broad definition of 
antioxidant, which could include indirect actions and an overall antioxidant effect on the 
cellular redox status.  
Perhaps more significantly, our analysis of the mechanism of action of fullerenes 
that show significant “antioxidant” activity raises several important questions that merit 
further investigation:  
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1) If these compounds tend to act initially as oxidizing agents, by accepting electrons,
why is it that we do not see more evidence of oxidative damage to cells, rather than the 
opposite? Could there be something about their structure that makes it easy for them to 
accept electrons from highly reactive free radicals like O2·− , but more difficult for them 
to oxidize typical biomolecules?  
2) If the native fullerenes have sufficient affinity for electrons from various sources
(including superoxide), is it possible that the resulting anionic fullerene species F·− (or 
F−n  with n>1) may be present in significant concentrations, such that they could be 
providing genuine reducing power, further contributing to the predominantly antioxidant 
effects that have been widely documented in cells? If so, why did their presence not show 
up as activity in the FRAP assay?  
It is of interest that, although the fullerene redox scheme shown in Figure 15.A 
has been clearly established for superoxide as substrate in both directions [67], not all 
free radicals could be easily oxidized by loss of an electron, as appears to be the case for 
the oxidation of O2·−  to O2  by C3 and other fullerenes (shown in the upper part of the 
cycle in Figure 15.A. However, a high turnover of O2·−  to O2 could generate enough F·−
to enable scavenging of other radicals that may only be scavenged by donation of an 
electron, i.e., reduction (shown in the lower part of the cycle in Figure 15.A. Such an 
asymmetric redox cycle in regard to preferred substrates could help explain the “net” 
antioxidant effects of these compounds, i.e., O2·−   may be selectively oxidized to 
generate reducing equivalents (F·− ) for the reduction of other ROS species that are not 
amenable to elimination by oxidation.  
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Until some of these questions can be answered, the fullerene paradox remains 
exactly that.
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CHAPTER III 
SOLUBLE FULLERENES INHIBIT NF-κB DRIVEN GENE EXPRESSION, VIA A 
MECHANISM OTHER THAN BLOCKADE OF NUCLEAR TRANSLOCATION 
Abstract 
The transcription factor Nuclear Factor κB (NF-κB) is the terminal effector of the 
predominant pro-inflammatory signal transduction pathways in animals. The effects of 
various fullerene derivatives on NF-κB signaling were investigated using cell-based 
assays, including an NF-κB-driven reporter gene assay, coupled with visualization of 
nuclear translocation of exogenous (transfected) NF-κB, via an NF-κB-GFP fusion 
protein expression construct. We report here for the first time direct evidence that some 
fullerene derivatives (specifically C3 and C60OHx) are effective inhibitors of NF-κB 
driven gene expression at micromolar concentrations.  However, unlike some 
antioxidants such as α-lipoic acid, they do not inhibit PMA-induced nuclear translocation 
of NF-κB, even at high concentration (40 µM). These and other results strongly suggest 
that fullerene derivatives block NF-κB signaling downstream of the cytosolic activation 
pathway (the site of action of many antioxidants), possibly inhibiting NF-κB activation at 
a step penultimate to DNA binding (e.g., the reductive nuclear activation of NF-κB by 
thioredoxin).  For fullerene derivatives to be clinical useful as anti-inflammatory agents, 
they must have acceptably low toxicity. Using cell proliferation/viability assays and 
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redox sensitive fluorescent dyes, we found that in living cells, several hydroxy and 
carboxy fullerene derivatives neither produce ROS nor cause any cytotoxicity, even at 
high micromolar concentrations. On the other hand, TTA and C60OHx fullerenes were 
found to decrease the intensity of tetramethylrhodamine methyl ester live cell staining, 
implying perturbation of the mitochondrial transmembrane potential. However, this effect 
is apparently not sufficient to decrease cell viability. Despite this caveat, taken as a 
whole, our results suggest that fullerenes are a promising class for the development of 
NF-κB inhibitors. 
Introduction 
Because of their unique molecular structure that is exclusively made of carbon 
atoms bonded in fused conjugated rings, fullerenes (C60 and C70 in particular) and their 
derivatives are the focus of many studies for elucidation of their properties and potential 
applications. Many interesting chemical and physical properties have been demonstrated, 
and significant biological properties are still being discovered.  
Fullerene research is advancing by developing their biological applications; 
several approaches are used to enhance their dispersion in aqueous suspension including 
exohedral functionalization [17, 19, 67, 102, 103] which is the addition of chemical 
groups on the surface of the fullerene cage. Those structurally modified fullerenes hold 
great promises in medical applications including; drug delivery [17] and magnetic 
resonance imaging MRI [29]. However a particular focus of recent studies has been to 
determine what researchers tend to describe as potential antioxidant properties of 
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fullerene derivatives, referring to their in vivo and in vitro biological roles [34, 66, 98, 
103-110]. 
Because of their ability to act as a free radical sponge, fullerenes are able to 
protect against oxidation- induced molecules, or what are known as reactive oxygen 
species. Reactive oxygen species (ROS) such as hydroxyl radicals, peroxides and 
superoxide radicals are produced from several cellular organelles as a result of cellular 
metabolic reactions. An electron transport chain occurs in mitochondria where electrons 
move in a stepwise path to reduce an oxygen molecule to form a water molecule; 
however, cellular dysfunction or injury induced as a result of chemical or environmental 
stress leads in turn to premature electron leakage to oxygen and therefore oxygen is 
reduced by fewer electrons, forming superoxide (O2·−) and, subsequently, hydrogen 
peroxide H2O2.   
Reactive oxygen species ROS have clearly detected roles in interference with cell 
signaling and apoptosis as well as causing generalized damage to biomolecules, through 
their interaction with lipids, DNA and proteins, thereby contributing to chronic diseases 
[40, 84, 111]. Interestingly it is important to know that many diseases are developed as a 
result of interference or modulation of cell redox pathways (reduction-oxidation balance) 
along with modification of various macromolecules [84]. Accordingly, an excess 
production of ROS as a result of cellular dysfunction or exposure to environmental 
stimuli such as light and smoke, coupled with the simultaneous decrease in antioxidant 
mechanisms, can shift the redox balance toward the oxidation state responsible for the 
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eventual development of many disorders such as cancer, cardiovascular diseases, and 
aging. 
Natural oxidative system like NADPH oxidase, mitochondria respiratory chain, 
xanthine-xanthine oxidase system generate reactive oxygen species in cells; superoxide 
(O2•-), hydroxyl radical (•OH) and hydrogen peroxide (H2O2). However our bodies 
neutralize or detoxify ROS by antioxidant systems such as superoxide dismutase (SOD), 
glutathione (GSH) and glutathione peroxidase (GPx) [53, 112-115]. The protective role 
of these protein or peptide antioxidants against protein oxidation is due to the presence of 
cysteine thiol residues in their active sites that reduce the oxidized protein disulfides by 
thiol exchange, contributing to an intracellular redox hemostasis [53, 54, 116-118]. 
Oxidized proteins are more susceptible to proteolysis and an increase in oxidized 
proteins produced by ROS might affect certain biochemical functions. Nuclear factor κB 
(NF-κB) is the terminal effector of the predominant pro-inflammatory signal transduction 
pathways in animals. NF-κB is a redox-regulated transcription factor found essentially in 
all cell types. NF-κB signal transduction can be activated by various noxious stimuli, 
including ROS, as well as  pro-inflammatory cytokines, TNF and interleukins (IL-1, IL-
2), pathogen-associated molecules like lipopolysaccharide (LPS), H2O2  and T-cell 
receptor induction [68-71]. ROS may thereby mediate changes in gene expression leading 
to interference with the nucleolus redox signaling [51, 119]. By binding to DNA, 
specifically to a sequence called a κB site (immunoglobulin kappa light-chain enhancer) 
[120], NF-κB controls the expression of an exceptionally large number of genes 
responsible for immune activation and inflammation, including cytokines, growth factors, 
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extracellular matrix protein, immune receptors, TNF-receptors (TNFR) and T-cell 
receptors [68]. Furthermore NF-κB, specifically its p65 subunit, plays an important role 
in apoptosis and cellular proliferation [121]. NF-κB is localized in the cytosol in an 
inactive form, as a result of binding to an inhibitor, a protein complex known as IκB. 
Stimulators regulate its activity by two pathways [122]; the canonical pathway is the 
classical NF-κB activation pathway that is stimulated by signals emanating from several 
cytokine receptors: TNF-receptors, interleukin (IL-1, IL-2) receptors, antigen receptors 
and pattern-recognition receptors, including most of the Toll-like receptors. Stimulation 
of NF-κB involves the disruption of NF-κB/IκB complex by IκB degradation. IκB kinase 
(IKK) phosphorylates IκB, consequently initiating its ubiquitination and proteasomal 
degradation. The IKK complex consists of IKKα, IKKβ, and IKKγ as the regulatory 
subunit (NEMO). This well elucidated signal transduction pathway activates p50/65 and 
p60/Rel-c heterodimers [123]. In contrast to canonical activation that is mediated by 
IKKβ- and NEMO- dependent manner, the non-canonical pathway depends on IKKα 
phosphorylation of p100, leading to proteasomal degradation of its C-terminus to 
generate p52, which forms transcriptionally active p52/RelB heterodimers of NF-κB 
[124]. The noncanonical pathway is triggered by certain TNF family cytokines, such as 
CD40L and lymphotoxin-β (LT-β). 
Notably, fullerene derivatives have attracted considerable interest as potential 
therapeutic drugs for treatment of diseases resulting from redox imbalance. Examples 
include: poly hydroxylated fullerenes known as fullerols or fullerenols (e.g. C60OHx) [34, 
108, 110, 125] which were shown to inhibit the production of angiogenesis factors, and 
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metastasis. C60(OH)24 was reported to inhibit carcinogenesis, malignant growth and 
doxarubicin induced cytotoxicity. Moreover, C60(OH)24 showed anti-genotoxic effects 
against anticancer drug-induced DNA damage, as well as a tissue-protective effect in 
irradiated cells. Likewise, carboxylated C60 fullerenes showed anti-apoptotic and 
neuroprotection activity [65, 74]. 
The redox properties of fullerenes can be predicted from their electrochemical 
structure. Their extensive conjugated double bonds and the delocalized LUMO with high 
electron affinity (2.683 eV for C60 and 2.765 eV for C70) make them function 
exceptionally well as electron acceptors. They tend to be electrophiles, accepting 
electrons from nucleophiles; consequently, fullerenes can be considered as potential 
oxidizing agents. A recent study made by our group involved the use of the FRAP assay 
(ferric reducing/antioxidant power) and an electron paramagnetic resonance (EPR) spin 
trapping technique for the elucidation of fullerene redox properties; results showed that 
fullerenes are poor reducing agents, suggesting the need for a reformulation of fullerene 
redox properties [126]. The ability to oxidize free radicals may be the basis of their 
activity as free radical scavengers, yielding a next antioxidant effect in cells. Therefore 
native fullerenes (prior to accepting additional electrons) are mostly likely not reductants 
or antioxidants, but are still able to function as free radical sponges via oxidation. 
However, the fullerene radical anion (F.−) formed by oxidizing a free radical (by 
accepting its unpaired electron) could then function as a direct reducing agent by 
donating its electron. Together these factors (oxidative radical scavenging, and the 
reducing ability of the fullerene anions so generated) are probably the basis of the 
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apparent antioxidant activity of fullerene derivatives reported by many previous 
investigators.  
The current study was designed to investigate our hypothesis that fullerenes could 
act as anti-inflammatory agents by inhibition of the NF-κB signal transduction pathway. 
The aim of this research is to investigate NF-κB signaling and  redox responses in 
MDCK cells after exposure to different fullerene derivatives (see Table 1 p. 32) and the 
possible mechanism of interaction of fullerene derivatives with NF-κB and cellular redox 
status.  
Studies of the mechanisms by which fullerene analogs are able to inhibit NF-κB 
driven gene expression involved examination of steps along the NF-κB signaling 
pathway, particularly the nuclear translocation of NF-κΒ, which is known to be enhanced 
by oxidative stimuli and increased ROS levels. Thus, by using an engineered conjugate of 
NF-κΒ with a fluorescent protein (GFP), the ability of NF-κΒ to enter the nucleus was 
assessed with and without the presence of the fullerenes. 
 
Materials and Methods 
Fullerene preparation. Fullerene samples were obtained as suspension in phosphate 
buffer saline PBS, from Luna Innovations, Inc. Samples was kept at 4°C when not in use.  
A different batch of hydroxylated fullerene was obtained from a commercial source in a 
powder form: C60(OH)24 (41182-MB 65-01-01, Alfa Aesar, A Johnson Matthey 
Company, Ward Hill, MA). The sample was dissolved in 1X PBS with long stirring for 
24-48 hours.  
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Cell Culture. MDCK (Madin-Darby canine kidney) cells (American Type Cell Culture 
ATCC, Catalog No. CCL-34, CCL-34) were grown under 5% CO2 at 37 °C, in 
Dulbecco’s Modification of Eagle’s Medium, DMEM, 1X (4.5 g/L glucose & sodium 
pyruvate without L-glutamine & phenol red) (cat.# 17-205-CV, Cellgro, Mediatech, Inc, 
Manassas, VA). This media was supplemented with 2 mM of L-Glutamine 200mM 
(100x) solution (Hyclone), 0.1 mM non-essential amino acid solution 100x (Sigma 
M7145) and 10% Fetal Bovine Serum. Cells used in the assays were at a passage number 
less than 20 (see appendix B). 
Cell Cytotoxicity. Cytotoxicity of water soluble fullerenes was tested at different 
concentrations against MDCK. The MTT and MTS proliferation assays were used (see 
appendix B, p. 141).  MTT is reduced by certain enzymes and converted from yellow 
tetrazole (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to 
insoluble purple formazan in living cells; dimethyl sulfoxide DMO is added to dissolve 
the insoluble purple formazan product into a colored solution. Using a spectrometer, the 
colored solution can be detected at an absorbance at 500-600 nm. MTS (CellTiter 96® 
AQueous one solution reagent, Promega) cell proliferation assay is composed of solutions 
of a novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] in the presence of the 
electron coupling reagent, phenazine methosulfate (PMS). The MTS assay is similar to 
the MTT, but it uses one solution instead of two. MTS creates a water soluble reaction 
product, thereby eliminating the DMSO solubilization step required with MTT. MTS is 
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reduced by intracellular metabolic enzymes into a soluble formazan product that can be 
detected at absorbance at 490-500 nm.  
Cells were seeded at a density of 2.0 x 105 cells/ml per well in a 96 well plate and 
incubated for 24 hours at 37 °C in 5% CO2.  Cells were exposed to various 
concentrations of fullerene derivatives; for the MTT assay, a range of concentration of 
0.003, 0.03, 0.39, 0.79, 4.69 and 8.6 µM of ALM, C60OHx and C3 were tested while for 
MTS a range of concentrations: 1, 10, 40 and 100 µM of C60OHx, TGA, TTA and C3 
were tested. T-Butyl hydrogen peroxide (TBHP) was used as a positive control. 
Measurement of NF-κB inhibition in 5KBpHIVLacZ transfected cells by β-
galactosidase reporter gene activity. Cells were transfected with a modified version of 
the plasmid pHIVlacZ which was obtained from NIH AIDS Research & Reference 
Reagent program (Cat# 151) and subsequently  engineered by the insertion of additional 
copies of the κB site (5’-GGGGACTTTCC-3’) into LTR sequence, for a total of 5 κB 
sites in the final construct pHIV-5κB-LacZ, to maximize cellular response to NF-κB 
[127] (see appendix C. p.144). Potential inhibitory activity of the three water soluble 
fullerenes; C60OHx, C3 and ALM against the HIV 3’LTR promoter activity was studied 
by the transfection of MDCK cells with pHIV-κB-LacZ using 96 well plates. MDCK 
cells with 50-70% confluency were tryptinized at 37 °C and 5% CO2 for 30 minutes, then 
resuspended in DMEM and seeded onto 96 well plates at a density of 2.0 x104 cells/well. 
After 24 hours further incubation at 37 °C and 5% CO2, the cells were transfected using 
0.22 µg DNA and 0.5 µl lipofectamine for each well, at a ratio of 1:2.3 plasmid DNA and 
lipofectamine 2000, diluted in OptiMEM medium. The DNA and Lipofectamine were 
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mixed together and allowed to stand for 20 minutes at room temperature before addition 
to the micro-plates. After one hour of transfection, a range of different concentrations of 
fullerenes (8.6 x10-6, 4.69 x10-6, 7.85 x10-7, 3.9 x10-7, 2.74 x10-8 and 3.04 x10-9 M) were 
added to cells. Phorbol myristic acid (PMA) was added at a concentration of 300 nM 
after 3 hours to stimulate transfection (2 hours after the addition of fullerenes) (see 
appendix C, p.146 for more details).  
Enhanced β-Galactosidase Assay Kit (genlatis A10100K) uses the chromogenic 
substrate chlorophenol red-β-D-galactopyranoside (CPRG). The expression of β-
galactosidase (β-gal) is measured by its cleavage of CPRG subsequently resulting in 
production of chlorophenol red, which is measured by colorimetric assay using a standard 
96 well plate reader. The assay was done following the manufacture instructions and 
absorbance was read at 575 nm with a microtiter spectrophotometer (see appendix C, 
p.147).
A visual intracellular localization study for the determination of fullerene effects on 
PMA induced NF-κB nuclear translocation. MDCK cells were transfected with GFP-
RelA obtained from Addgene. Cells were seeded in 96 well plates at a concentration of 
2.0 x105 cells/ml, after 24 hours of incubation, cells were transfected with GFP-RelA. 
Transfection was done using 0.22 µg DNA and 0.5 µl lipofectamine 2000 (Invitrogen 
11668-019) for each well, at a ratio of 1: 2.3 of plasmid DNA and lipofectamine 2000, 
diluted in OptiMEM medium. The DNA and Lipofectamine were mixed together and 
allowed to stand for 20 minutes at room temperature before the addition to plates. After 
24 hours of transfection, cells were treated with fullerenes at a final concentration of 40 
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µM. Nuclear transfection was induced after 24 hours of fullerene treatment by using 
Phorbol 12-myristate 13-acetate, PMA (Sigma, P1585-1MG, C36H50O MW: 616.83).  
Determination of mitochondrial membrane potential (ΔΨm) and ROS level. The 
fluorescent dye TMRE (Tetramethylrhodamine ethyl ester perchlorate, Sigma, 87917-
25MG, LOT # BCBK3586V) was used for the detection of mitochondrial membrane 
potential. (ΔΨm). MDCK cells were seeded at a density of 2x105cells/ml in four 
chambers cell dish, after 24 hours incubation, cells were labeled with 100 nM of TMRE 
for 5-10 minutes followed by incubation for 90 minutes with the absence (control) or 
presence of 40 µM of the following;  C60OHx, NAC and TTA at 37 °C in 5% CO2.  
FCCP [carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone]) was used at 1 µM 
concentration as an inhibitor of the mitochondria functionality which is demonstrated by 
a reduction in TMRE fluorescence. After washing, cells were immediately observed by 
confocal microscope with an acquisition at red channel to visualize TMRE fluorescent 
changes. A change in TMRE intensity is proportional to a change in the mitochondria 
membrane potential (ΔΨm). 
Reactive oxygen species (ROS) formation was analyzed by measuring the 
conversion of the non-fluorescent dye H2DCFDA (2’,7’- Dichlorofluoresceine, 
C24H16C12O7 Sigma, D6883-50MG, LOT# 092M4004V, CAS: 4091-99-0) to the highly 
fluorescent 2,7-dichlorofluorescein (DCF) upon oxidization by radicals. MDCK cells 
were seeded at a density of 2x105cells/ml in 96 well black plates. After 24 hours, cells 
were loaded with 5µM H2DCFDA for 10 minutes. Thereafter, cells were treated with 40 
or 100 µM of TBHP, NAC and fullerenes (C60OHx, TGA, TTA and C3). TBHP was used 
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as positive control for ROS production at 40 and 100 µM. The fluorescent DCF was 
measured spectroscopically after 90 minutes incubation with fullerenes at 480/529 nm. 
The protective role of fullerenes against TBHP toxicity was studied by incubating cells 
with fullerenes 24 hours before TBHP treatment. 
Western blot analysis of NF-κB activity. For the analysis of NF-κB activation, cells were 
seeded at a density of 3 x105 cells/ml for each well in a 6 well plate and incubated for 24 
hours at 37 °C, thereafter 40 µM of C60OHx was added and after 24 hours of incubation, 
PMA was added to induce nuclear translocation at a concentration of 25 µM. After 5 
hours of incubation, cells were lysed using NF-κB extraction kit (NFKB-2, Fivephoton 
biochemical, San Diego, California). Cell lysates were fractionated by 4–20% SDS-
PAGE gel (mini- Protean TGX, Bio-Rad. Cat. 456-1093), 30 µl of protein was loaded on 
and the gel was run for 15 minutes at 300 volts. The gel was subsequently transferred 
onto a nitrocellulose membrane using Trans-Blot Turbo Transfer system. Primary 
antibody P65 (No. p65Ab, Rab IgG, Lot 388, Fivephoton Biochemicals) was used at a 
dilution of 1:400 and  Secondary antibody Goat Anti – Rab IgG- HRP was used at 
1:3000. Proteins were detected by an enhanced chemiluminescence (ECL) reagent using 
a commercial kit (see appendix C, p.149 for more details). 
Results 
Cell Cytotoxicity. Our study showed the biocompatibility of different fullerene 
derivatives, there was no cytotoxic effect observed using either the MTT or MTS cell 
proliferation assays (Figures 17 & 18).  There was no inhibition of cell growth or 
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induction of morphological changes compared to the untreated cells at any tested 
concentration. 
 
 
 
 
 
 
 
 
 
Figure 17. The colorimetric MTT proliferation assay was used to test cell viability after 
incubation with C60OHx, C3 and ALM. MDCK Cells were seeded at a density of 2.0 
x105 cells/ml in a 96 well plate and incubated for 24 hours at 37 °C in 5% CO2. Cells 
were further incubated at the absence (control) or presence of various concentrations of 
fullerene derivatives, 0.003, 0.03, 0.39, 0.79, 4.69 and 8.6 µM of ALM, C60OHx and 
C3. The resulted colored solution was detected at 570 nm using a spectrometer. The 
absorbance values represent the mean of four readings and the corresponding standard 
errors of the means (s.e.m.). T-test was conducted and there were no significant 
differences between the means. 
63 
 
 
 
Figure 18. The colorimetric MTS proliferation assay (CellTiter 96®AQueous one 
solution reagent) was used to test the viability of cells incubated with water soluble 
FULLERENES. MDCK cells were seeded at a density of 2.0 x 105 cells/ml in 96 well 
plates and incubated for 24 hours at 37 °C in 5% CO2, cells were incubated for further 
24 hours at the absence (control) or presence of various concentrations of fullerene 
derivatives; 1, 10, 40 and 100 µM of C60OHx, TGA, TTA and C3. TBHP was used as 
positive control. The resulted colored solution was detected at 490 nm using a 
spectrometer. The absorbance values represent the mean of four readings and the 
corresponding standard errors of the means (s.e.m.). T-test was conducted and there 
was a significant reduction in cell growth in the case of 100 µM TBHP. TTA at 100 
µM concentration resulted in a significant increase in cell growth. 
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Measurement of NF-κB inhibition in 5KBpHIVLacZ transfected cells by β-
galactosidase reporter gene activity. NF-κB activity assay was plotted as log values of 
fullerene concentrations (x axis) versus absorbance (relative β-gal activity) as % of 
control. Fullerol (C60OHx) and C3 inhibited the activity of NF-κB at concentration 8.6 
µM (Figure 19) supporting their role as a free radical sponge. The sigmoid curve (dose 
response curve) shows that low concentrations of fullerol increased the NF-κB response 
above 100%. It should be noted that the observed inhibitory effect was recorded for 
fullerol and C3, while ALM showed no inhibitory reaction. The inhibition of the 
expression of genes under the regulation of NF-κB suggested that fullerenes suppress 
signaling downstream, penultimate to the DNA binding step.
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Figure 19. The curve (log-dose response curve, sigmoidal in shape) shows the 
INHIBITORY effect of C60OHx, C3 and ALM on the activity of NF-κB. The following 
concentrations were tested; 8.6 x10-6, 4.69 x10-6, 7.85 x10-7, 3.9 x10-7, 2.74 x10-8 and 
3.04 x10-9 M.  High concentrations (8.6 x10-6 and 4.69 x10-6) of C60OHx and C3 
resulted almost in a complete inhibition. Low concentrations of C60OHx (3.9 x10-7, 2.74 
x10-8 and 3.04 x10-9 M) increased the NF-κB response (Hormesis). The absorbance as 
% of the control values represents the mean of four readings and the corresponding 
standard errors of the means (s.e.m.). 
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A visual intracellular localization study for the determination of fullerene effects on 
PMA induced NF-κB nuclear translocation. For visualizing the translocation of NF-κB 
from the cytosol to nucleus, a GFP-p65 construct was used for the transfection of cells 
and its localization in the cells was monitored by fluorescence microscopy. In PMA 
stimulated cells, the expressed p65 was translocated to the nucleus within three hours 
(Figure 20.A), TBHP induced NF-κB translocation as well (Figure 20.B). The presence 
of antioxidant NAC (Figure 20.C) did not inhibit the translocation whereas antioxidant 
LA did (Figure 20.D).  Fullerene derivatives did not inhibit NF-κB translocation (Figure 
21).
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Figure 20. PMA induced nuclear translocation of NF-κB. MDCK Cells were transfected 
with GFP-RelA plasmid encoding p65. After 24 hours of transfection, cells were 
incubated only with 25 µM PMA (A), cells incubated only with 40 µM TBHP (B) and 
cells were simultaneously incubated with 25 µM PMA and either 40 µM NAC (C) or 40 
µM lipoic acid, LA (D). Time lapse imaging of PMA induced NF-κB nuclear 
translocation was done using the EVOS FL microscope (AMG Micro, Bothell, WA, 
USA, at 20× magnification). Nuclear translocation occurred within 3 hours of PMA 
incubation. 
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Figure 21. Fullerene treatment causes NO inhibitory effect on PMA induced 
nuclear translocation of NF-κB. MDCK Cells were transfected with GIF-RelA 
plasmid encoding p65. After 24 hours of transfection, cells were incubated 
simultaneously with 25 µM PMA and 40 µM of either C60OHx (A) or C3 (B). 
Another group of cells were incubated with 40 µM C3 for 24 hours prior to PMA 
addition (C). Time lapse imaging of PMA induced NF-κB nuclear translocation 
was done using the EVOS FL microscope (AMG Micro, Bothell, WA, USA, at 20× 
magnification). Nuclear translocation occurred within 3 hours of PMA incubation. 
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Determination of mitochondrial membrane potential (ΔΨm) and ROS level 
Figure 22. Detection of mitochondrial membrane potential (ΔΨm) of MDCK cells. MDCK cells were labelled with 100 
nM of the fluorescent dye TMRE (tetramethylrhodamine methyl ester) for 5-10 minutes followed by incubation with 
the absence (control) or presence of 40 µM of the following; C60OHx, NAC and TTA for an hour and a half at 37 °C in 
5% CO2.  FCCP [carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone]) was used at 1 µM concentration as an 
inhibitor of the mitochondria functionality which is demonstrated by a reduction in TMRE fluorescence. A change in 
TMRE intensity is proportional to a change in the mitochondrial membrane potential (ΔΨm). Notice the reduction of 
intensity upon using fullerenes. 
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Figure 23. Investigation of the generation of
 
  reactive oxygen species (ROS) in the presence 
of fullerene derivatives. For the detection of  ROS generation, (ROS) formation was 
analyzed by measuring the conversion of the  non-fluorescent dye H2DCFDA (2’,7’- 
Dichlorofluorescence, C24H16C12O7) to the   highly fluorescent 2,7-dichlorofluorescein 
(DCF). After 24 hours of seeding MDCK ce lls, they were loaded with 5µM H2DCFDA for 
10 minutes. Thereafter, cells were treated w ith 40 or 100 µM of one of the following; tertyl 
butyl hydrogen peroxide (TBHP), NAC, LA and fullerenes (C60OHx, TGA, TTA and C3). 
Tertyl butyl hydrogen peroxide (TBHP) was used as positive control for ROS production 
at 40 and 100 µM, The radical mediated oxidation converts the non-fluorescent form of the 
dye to the fluorescent DCF which was measured spectroscopically after 90 minutes at 
480/529 nm. Relative values compared to TBHP treated cells (Control 100%) are shown 
which represent the mean of four readings and the corresponding standard errors of the 
means (s.e.m.). * Significantly different from zero. Fullerenes did not result in free radical 
generation. 
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Figure 24. Detection of the PROTECTIVE roles of fullerene derivatives against 
TBHP toxicity. Reactive oxygen species (ROS) formation was analyzed by 
measuring the conversion of the non-fluorescent dye H2DCFDA (2’,7’- 
Dichlorofluorescin, C24H16C12O7) to the highly fluorescent 2,7-dichlorofluorescein 
(DCF). After 24 hours of seeding MDCK cells, they were loaded with 5µM 
H2DCFDA for 10 minutes. Thereafter, cells were simultaneously incubated with 40 
or 100 µM of TBHP and either C60OHx or NAC. Tertyl butyl hydrogen peroxide 
(TBHP) alone was used as positive control for ROS production at 40 and 100 µM, 
The radical mediated oxidation converts the non-fluorescent form of the dye to the 
fluorescent DCF which was measured spectroscopically after 90 minutes at 480/529 
nm. Relative values compared to TBHP treated cells (Control 100%) are shown 
which represent the mean of four readings and the corresponding standard error of 
the mean (s.e.m.). * Significantly different than the control. NAC significantly 
decreased radical generation and protected against TBHP toxicity at 100 µM. 
C60OHx did not provide significant protect against TBHP induced toxicity. 
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F i gu r e 25. Determination of the PROTECTIVE roles of fullerene derivatives against 
T BH P toxicity. Reactive oxygen species (ROS) formation was analyzed by 
m e a s uring the conversion of the non-fluorescent dye H2DCFDA to the fluorescent 
( D C F) in cells preincubated with fullerenes and treated with TBHP thereafter. 
M D CK were incubated for 24 hours with 40 or 100 µM of one of the antioxidants; 
N A C , Vitamin C and LA and one of fullerene derivatives (C60OHx, TGA, TTA and 
C3). Following the incubation, cells were incubated for 5-10 minutes with 5 µM of 
H 2D CFDA fluorescent and 40 or 100 µM of tertyl butyl hydrogen peroxide (TBHP) 
w a s a dded to cells to induce ROS production. After 90 minutes incubation, the 
f l uor escent DCF was measured spectroscopically at 480/529 nm. Relative values 
c om pared to TBHP treated cells (Control 100%) are shown which represent the 
m ean of four readings and the corresponding standard errors of the means (s.e.m.).   
* Significantly different. Preincubation of cells with C3 resulted in a significantly
reduced radical generation induced by TBHP. Vitamin C significantly reduced ROS 
level and protected against TBHP toxicity. 
Western blot analysis of NF-κB activity. Nuclear translocation of NF-κB is a critical step 
in NF-κB activation. Immunofluorescence analyses using anti-p65 antibody for the 
cytosol extract have revealed that PMA induced translocation of NF-κB in the nucleus 
was stimulated more in C60OHx treated cells.  
Figure 26. WESTERN BLOT analysis of MDCK cells stimulated with 25 µM PMA for 5 
hours, the result shows a detectable decrease in expression in the cytosol corresponding 
to an activity stimulation of p65 in nucleus. C60OHx resulted in lower p65 protein level in 
the cytosol extracts as well.  
Discussion 
As a pro-inflammatory mediator in the immune system, NF-κB is activated upon 
exposure to various noxious stimuli such as cytokines, pathogens, free radicals and other 
ROS like peroxides. Once activated in the cytosol, NF-κB translocates to the nucleus, 
where it binds to its cognate DNA sequences and activates target genes. Because ROS, 
particularly H2O2, activate the NF-κB pathway, the widely observed inhibition of NF-κB 
by many antioxidants is not surprising. However, there is a growing appreciation of the 
complexity of NF-κB activation and regulation by ROS, and the inhibitory mechanisms 
of antioxidants [128, 129]. One study showed that overexpression of exogenous catalase 
did not inhibit NF-κB activation stimulated by TNF/PMA, leading the authors to question 
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the role of H2O2 as a second messenger for TNF/PMA induction of NF-κB activation 
[71]. Another study found that NF-κB activation by H2O2 depends on cell type; 
EL4.NOB-1 T and KB epidermal cells were not activated by H2O2. Moreover, 
antioxidants such as NAC failed to inhibit activation of those cells after stimulation with 
TNF.  
On the other hand, H2O2 has been widely used to activate NF-κB in many 
studies, and NAC has an inhibitory effect on NF-κB in Jurkat cells after TNF treatment 
[69]. The natural thiol antioxidant α-lipoic acid (LA) has been studied as a potential anti-
inflammatory drug for blocking the NF-κB pathway; it was found that LA inhibited NF-
κB activation stimulated by TNF or PMA in Jurkat cells [130]. LA is significantly more 
potent than NAC, and, like NAC, has been used as a “complementary” therapy for HIV/
AIDS. Both Pyrrolidine dithiocarbamate (PDTC) and NAC block NF-κB activation via a 
pathway independent of their activity as antioxidants; NAC was found to act by lowering 
the affinity of TNF receptor to TNF, while PDTC suppresses the IκB–ubiquitin ligase 
activity [131]. 
The modulation of NF-κB activity by fullerenes has not been very well studied. 
One of the few relevant previous studies showed that fullerene derivatives act as potent 
inhibitors against PMA-induced inflammatory response. However, their mechanism of 
inhibition was not clear; it was suggested that fullerenes act by decreasing levels of ROS 
responsible for inducing inflammation after treatment with PMA [75]. Another study 
used polymer wrapped fullerenes, Polyvinylpyrrolidone (PVP) fullerene, to protect 
against UVA-induced cell death by the inhibition of NF-κB activation [132]. 
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We report here for the first time direct evidence that some fullerene derivatives 
are effective inhibitors of NF-κB-driven gene expression. Specifically, a representative 
carboxy (tris-malonyl) fullerene derivative (C3) and a hydroxy fullerene (C60OHx) were 
tested and found to be active; both fully inhibited NF-κB driven β-gal expression at 
micromolar concentrations (Figure 19) that are non-toxic to cells (Figures 17 & 18). In 
contrast, the highly lipophilic fullerene ALM was inactive as an NF-κB inhibitor (Figure 
19), perhaps because it cannot easily pass through the cytosol to the cell nucleus. 
However, unlike some antioxidants such as α-lipoic acid, the active fullerenes were 
found to have no effect on PMA-induced nuclear translocation of NF-κB, even at high 
concentration (40 µM).  
Regarding the effects of  different oxidants (TBHP), antioxidants (NAC and LA) 
and fullerenes on PMA induced nuclear translocation in our experiments, it should be 
noted that exogenous (transfected) NF-κB as an NF-κB-GFP fusion protein expression 
construct was introduced to cells to monitor nuclear translation in response to PMA 
treatment. Our results are in agreement with a previous study that found that the thiol 
antioxidant NAC did not inhibit the nuclear translocation of NF-κB in cells 
overexpressing (transfected) p65 [133]. NAC was used to detect the role of redox 
response in NF-κB signaling pathway induced by TNF alpha. The same study found that 
NAC inhibited endogenous NF-κB activation through the suppression of phosphorylation 
by kinases, however, NAC failed to inhibit kinase activity in vitro, indicating that NAC 
mediates the suppression of the kinases IKKα and IKKβ through an unknown redox 
mechanism. In contrast to vitamin C or glutathione, LA was found to inhibit IκB/NF-κB 
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signaling pathway at the level, or upstream, of IκB kinase [134], blocking nuclear 
translocation of NF-κB. LA acid is the most potent of the common thiol antioxidants, and 
in our hands, it was the most potent translocation blocker, with no GFP fluorescence 
visible in the cell nuclei three hours after combined PMA and LA treatment; in 
comparison, NAC at best gave only a minor reduction in translocation (Figure 20).  
Thus, the fullerenes that were effective inhibitors of NF-κB-driven gene 
expression (C3 and C60OHx) had no effect at all on NF-κB nuclear translocation (Figure 
21), suggesting that their mechanism of action is distinct from that of a potent antioxidant 
like LA, which inhibits NF-κB signaling by blocking its nuclear translocation. Taken 
together, these results strongly suggest that the active fullerene derivatives block NF-κB 
signaling downstream of the cytosolic activation pathway (the site of action of many 
antioxidants), possibly inhibiting NF-κB activation at a step penultimate to DNA binding. 
One such step is the reductive activation of NF-κB by Trx in the nucleus, which is 
essential for any effect of NF-κB on gene transcription, because the oxidized disulfide 
form of NF-κB is sterically blocked from binding to DNA [135]. This suggests a need for 
further studies of the interactions of fullerenes with the Trx system.     
Tert-butyl hydroperoxide (TBHP) is an amphiphilic peroxide that is structurally 
similar to hydroperoxides that result from lipid peroxidation, which contributes to cellular 
dysfunction and disease. TBHP is a highly reactive strong oxidant with a long half-life 
which can pass with ease through the membrane and migrate in the cell. TBHP activates 
the NF-κB pathway by inducing the phosphorylation of inhibitor of kB (IkB) through the 
IkB kinase (IKK) pathway, which involves p38 MAPK and ERK. For these reasons, 
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TBHP was used in our experiments as a positive control to enhance NF-κB nuclear 
translocation (Figure 20), as well as ROS formation and toxicity in cells (Figures 23, 24 
& 25), wherein the ability of fullerenes to antagonize TBHP-induced toxicity in cells was 
investigated by analyzing ROS level using a fluorescent probe. Fullerenes were not 
significantly effective in protecting against TBHP toxicity (Figures 24 & 25), which may 
primarily reflect the potency of THBP as an oxidant, because TBHP cytotoxicity was also 
not very effectively prevented using common antioxidants such as vitamin C and NAC at 
a concentration of 40µM; however vitamin C at 100 µM significantly reduced TBHP 
cytotoxicity. The previous results indicate that higher drug concentrations are needed to 
prevent cytotoxicity induced by TBHP in MDCH cells. NAC was previously reported to 
require very high concentrations (millimolar) to protect against cytotoxicity induced in 
cells [136]. 
It is important to note that none of the 4 carboxy or hydroxy fullerenes tested was 
found to increase ROS levels when exposed to cells as a mono therapy (Figure 23). Thus, 
despite their paradoxical role of scavenging free radicals by oxidation [126], the carboxy 
and hydroxyl fullerenes under study apparently do not indiscriminately oxidize other cell 
components other than free radicals. This probably contributes to their low toxicity, 
which is of considerable importance, because, for fullerene derivatives to be clinical 
useful as anti-inflammatory agents, they must have acceptably low toxicity.  
The fullerene derivatives tested here were not toxic in MDCK cells at 
concentrations up to high micromolar (Figures 17 & 18), which is in agreement with 
previous literature. Several previous in vivo and in vitro studies have shown that 
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fullerenes have no acute or subacute toxicity [137, 138]. However, some aqueous 
dispersion of fullerenes have been reported to induce oxidative damage in bacteria, algae 
and fish. Fullerene cytotoxicity is highly variable and depends on factors such as: particle 
size, aggregation state, shape, the degree of cage derivatization, chemical composition, 
surface charge and chemistry, water solubility, light exposure as well as dispersion [91, 
139]. Therefore the literature contains some contradictory findings. The toxicity of 
aggregated fullerene particles in aqueous solution was reported at very low concentration 
part per billion (ppb) against human cell lines, the toxicity was exhibited by cell 
membrane peroxidation resulted from reactive oxygen species (ROS) [91]. In all studies 
which showed the toxicity of nC60 used tetrahydrofuran (THF) or dimethyl sulfoxide 
(DMSO) as solvent for the preparation of nC60 or other fullerene derivatives [15, 64, 140-
142]. It was also claimed that some colorimetric methods used to detect ROS production 
[31, 91] were found to interfere with nC60 and produce false positive results [143-145]. 
Because different fullerene structures have distinct cytotoxic mechanisms, fullerene 
derivatives must be evaluated individually [140]. Fullerenes have been shown to suppress 
production of ROS in a number of studies, e.g.[146-148]. 
Finally, our results do show that fullerenes may cause some perturbation of 
mitochondrial function (Figure 22), which is in agreement with previous in vivo and in 
vitro studies of liver cells [136, 149], where hydroxylated fullerenes caused  hydrogen 
ion depletion in cells, possibly due to their disruption of ATP synthesis in the 
mitochondria [150]. This could be interesting in the light of evidence of anti-aging effects 
of some fullerenes like C3 [74], if slowing down of mitochondrial function could mimic 
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the effects of dietary caloric restriction. However, this effect on mitochondria is 
apparently not sufficient to decrease cell viability (Figures 17 & 18). Despite this caveat, 
taken as a whole, our results suggest that fullerenes are a promising class for the 
development of NF-κB inhibitors. NF-κB [120] and fullerenes [4] were discovered just 
one year apart, so it will be an interesting coincidence if fullerenes prove to be an 
important chemical class for the development of potential anti-inflammatory drugs that 
act by inhibition of NF-κB signaling.
80 
  
CHAPTER IV 
 
PHYSICAL CHARACTERIZATION OF FULLERENES 
 
 
The structure of fullerene C60 consists of 60 vertices and 32 faces, comprising 12 
pentagons and 20 hexagons folded into a sphere of 1 nm diameter [4]. The atoms are 
connected by sp2 hybridized bonds in which every carbon atom forms bonds to three 
other adjacent atoms, resulting in its pseudo-aromatic structure due to its conjugated 
double bonds and the delocalization of π-electrons over its carbon core.  There are two 
types of bonds in fullerene: C5–C5 single bonds in the pentagons and C5–C6 double 
bonds in the hexagons [148]. There are 12 pentagon rings in fullerenes regardless their 
size, thus each fullerene Cn, n=any even number, is constructed of 12 pentagonal rings, 
and any number of hexagonal ones, m such that m= (n-20)/2 (Euler’s rule). 
There is a large gap between the energy of the highest occupied molecular orbital 
(HOMO) and the lowest unoccupied molecular orbital (LUMO) [151]. The energy 
separation between HOMO and LUMO have been roughly used as an indicator of kinetic 
stability for fullerenes, specifically, susceptibility to chemical reactions and 
decomposition. However as fullerene size increases, the HOMO-LUMO energy 
difference becomes smaller [152]. 
Early spectroscopic studies for the existence of fullerenes assumed that C60 would 
be an extremely stable aromatic molecule. This view was supported by the calculation 
that there are 12,500 resonance structures possible for C60. But this overlooks an 
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important feature, C60 has the tendency to avoid having double bond character in the 
pentagonal ring. The presence of double bonds shortens bonds in the already strained 
ring, producing the Mills-Nixon effect. There is thus only one structure for C60 that 
avoids having any double bonds in pentagonal rings, and this has two important 
consequences; first, the delocalization of electrons is poor, so C60 is much more reactive 
than originally expected, otherwise C60 would have all the chemical excitement of brick 
dust. Second, C60 is not so much an aromatic molecule as a giant closed cage alkene. The 
same applies to other fullerenes. The stability of fullerene derivatives is largely controlled 
by avoiding double bonds in the pentagonal rings, which is also important in determining 
which fullerene isomers are stable. 
Unlike aromatics, fullerenes have no hydrogen atoms or other groups attached and 
so are unable to undergo substitution reactions. Substitution reactions can take place on 
derivatives once these have been formed by addition. As the cage consists entirely of sp2 
hybridized carbon, which have electron withdrawing inductive effects, the fullerenes are 
strongly electron attracting. This affects their chemical behavior; for example, they react 
readily with nucleophiles. In general, the molecules appear to undergo all the reactions 
associated with poorly conjugated and electron deficient alkenes. But their unique feature 
is the vast number of products that may arise from addition of just one reagent [153]. The 
thirty conjugated double bonds attribute to C60 a propensity to addition reactions. In order 
to enhance their water solubility and their interaction with the biological systems, 
fullerenes are commonly modified chemically by directly binding moieties to the carbon 
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cage.  Such fullerene compounds includes polyhydroxylated C60 (fullerenol), and tris 
malonyl C60 or C3 (carboxylated fullerenes). 
The behavior of fullerene derivatives in aqueous solution is complex and as a 
consequence their interaction with the biological system is far from well understood. 
Both derivatization and preparation can change the physical properties resulting in 
nanoscale aggregates with distinctly different properties from the parental molecule. 
Therefore, it is essential to study fullerene physical properties, including agglomeration 
state, size distribution of agglomerates, solubility in terms of the biological media, indeed 
the variable nanomaterials activity or responses is based on characterization in media 
rather than drawing a general conclusion for the whole class of nanomaterials. The type, 
number and placement of substituents can dramatically impact the physiochemical 
properties of fullerenes and subsequently their activities and interaction with biological 
systems and uptake by cells. For further development of their medical applications, more 
understanding is needed for their behavior in different conditions.  
In addition to the relatively expensive prices, low availability of derivatized 
fullerenes restricts their chemical structure characterization; although nanogram to 
microgram quantities is enough to induce biological activities, milligrams of fullerenes 
are needed for chemical and structural analysis. Another challenge is that most fullerene 
derivatives fail to maintain their structure upon characterization, particularly in a mass 
spectrometer; most C60 derivatives gave only one peak at 720 a.m.u corresponding to the 
core (C60). 
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Despite the recorded biological activities of polyhydroxylated fullerenes in vivo 
and in vitro[64, 98, 105], the number of hydroxyl groups attached is difficult to determine 
and can vary from 2-30 or higher than 30, depending on production conditions; this 
results in molecules with different solubility and activity.  However most of the 
biological research on hydroxylated fullerenes has focused on fullerenols with a number 
of hydroxyl groups below 30. Little is known about the bioactivity of highly 
hydroxylated fullerenes (over 30 OH groups). 
Along with hydroxyl groups, other groups such as salt and oxygen Сn(ОН)xОy 
might be present in fullerenol solution, therefore it is not possible to describe fullerenol 
solution as highly pure >99% while they might be (>95%). As a result, heterogeneous 
fullerenol solutions (mixed solutions) are cheaper, so typically there are other types of 
chemical groups in mixed fullerenol solutions and they might also have traces of heavier 
fullerene cores, C70, to C96 [154]. 
It is important to consider while preparing fullerenol solutions for 
pharmacological purposes that pH value changes with concentration for fullerenol 
solution as a result of proton dissociation. A concentration of 0.1 mM of fullerenol 
solution yields a pH change of about 0.1, while for about 2 mM, this change is about 1, 
which results in a pH of 6.[155]. Because hydrogen dissociation of fullerenol solution 
changes the pH of aqueous solutions, fullerenol solution acts as a weak acid. A similar 
effect is expected for the dissociation of K+ in the other fullerene derivative solutions.  
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Fullerene derivatives have a high propensity to form aggregates in solution; 
hydroxylated fullerenes tend to form aggregates in polar solution with a size range of  
20–100 nm [14, 137, 156] while TGA was found to form 20-50 nm aggregates [137]. 
 
Materials and Methods  
Mass spectrometry, optical spectroscopy, zeta potential and size were used in this 
study for characterization of fullerene derivatives. Mass spectrometry (Figure 27) is used 
commonly to check the purity and to detect the chemical composition of fullerenes, 
however the ionization process may result in generation of new carbon species from the 
pure sample. Another consideration is the extensive fragmentation of C60, which leads to 
peaks less than m/z 720 (peak at 720 m/z corresponds to C60) indicating unreliable 
impurities in the sample.  For these reasons, mass spectra do not reflect purity higher than 
99%. 
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Figure 27. MASS SPECTROMETRY scheme process. The molecules must be charged 
(converted into ions) before measuring in MS. The accelerated charged particles are 
deflected by a magnetic field according to their masses and charges. Mass analyzer 
separates travelled ions based on mass to charge ratio (m/z). Detector counts number of 
ions for each m/z, amplifies the ion signal and transfers it to data system, which displays 
the analysis to a spectrum (m/z values of the ions vs. their intensities). MS process is 
under the control of data system. 
 
 
MALDI/TOF, Matrix Assisted Laser Desorption/Ionization Time of Flight Mass 
Spectroscopy. MALDI/TOF technique was used in this study to identify cross 
contamination of fullerenes in solution, and not for quantitation purposes. MALDI, 
matrix assisted laser desorption ionization, is the ion source, considered as soft ionization 
method and TOF, time of flight is the mass analyzer. Some advantages of using 
MALDI/TOF include the tolerance of salts and buffers, fast data acquisition and 
sensitivity for small quantities. The acidic matrix (α-CHCA; cyano-4-hydroxycinnamic 
acid) was selected, and 1-3 µl of fullerene solution was loaded into a plate (Figure 28). 
The mix ratio is 10,000:1 matrix to sample, the mixture was dried for 5 minutes to allow 
co-crystallization of matrix with the sample. 
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Figure 28. Sample preparation on a standard plate for MALDI with multiple wells. 
Sources: [157] and www.ms-textbook.com). 
 
 
The MALDI plate was placed into the MALDI plate holder. The sample is then 
irradiated with a laser (positive mode) (Figure 29) and the generated analyte ions pass 
through a flight tube based on their mass to charge ratio. Mass analyzer TOF detects the 
analytes at different times.
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Figure 29. A representative scheme of MALDI. Sample A (analyte) is mixed with excess 
matrix (M) and allowed to dry on plate to form crystals. Irradiation of the mixture by 
laser causes ionization of the matrix molecules (MH+), the ionized matrix transfer a 
proton to the analyte thus ionizing the analyte. MH+  +  A             M  + AH+. Accelerated 
ions enter the time of flight tube, where lighter ions travel faster than heavy ones, 
reflecting their mass, so smaller ions reach the detector first [158]. 
 
 
Optical Spectroscopy. Despite the paucity of information that can be obtained from 
optical spectra of fullerenes, they still can be used to determine heterogeneity of 
fullerenes in solution. The optical absorption spectra obtained depend on the size and 
structure of fullerenes. As the LUMO HOMO gap becomes smaller with increasing size 
of the fullerene, less energy is needed for electron transition, thus larger fullerenes absorb 
light at longer wavelength. For that particular reason, the presence of certain peaks in 
solution can provide a method for detecting C70 impurities in C60 solution. A Biotek 
SynergyTM Mx microplate reader was used for the measurement using Gen5 software, 
version 1.09.8 (BioTek Instruments, Inc., Highland Park, Winooski, VT). In this study we 
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used spectrophotometry to measure the optical absorption of fullerene derivatives in the 
range 280-880 nm. A UV-Visible absorbance spectrophotometer was also used for 
characterization of C3, C60OHx and ALM. Quartz cuvette (1 cm) was used and phosphate 
buffer saline was used as the background solution. Absorbance was collected between 
202-802 nm. 
Zeta potential and Zeta size. We used Malvern Zetasizer Nano Z ZS90 (Malvern 
Instruments Ltd), which uses both techniques of Dynamic Light Scattering, DLS and 
Laser Doppler micro-electrophoresis for the measurement of size and charge respectively 
of carbon nanoparticles. DLS measures the diffusion of moving particles which have 
been dissolved in a liquid, particles movement due to Brownian motion (which is the 
movement of particles due to random collision) causes laser light to be scattered at 
different intensities. DLS analyses these intensities by converting them to velocity of 
Brownian motion and hence, size and size distribution, by using the Stokes-Einstein 
relationship.  
The Zeta potential technique uses laser Doppler electrophoresis to measure the 
velocity of particles in solution when electric field is applied (known as electrophoretic 
mobility), then zeta potential is calculated by using viscosity and dielectric constant 
based on Henry’s equation. Zeta potential is important for the determination of the 
tendency of particles to flocculate in solution, indicating the stability of particles. Zeta 
potential values larger than +30 mV or -30 mV represent stable particles with no 
tendency to flocculate.  
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By using the software, we created a SOP (Standard operating procedure) for 
measuring fullerenes. Physical properties of sample were set including the refractive 
index, viscosity cP and dispersant dielectric. The refractive index values were 1.9, 1.332, 
1.33 and 1.365 for fullerenes, PBS, water and DMEM respectively. Viscosity (cP) values 
of PBS, water and DMEM were; 0.891, 0.8872, 1.054 respectively and the dispersant 
dielectric constants of PBS, water and DMEM were; 78.6, 78.5 and 80.0 respectively. 
The size analysis result are shown as a size distribution graph represented in two 
ways, the descriptive values (cumulant analysis) which includes both Z-average (intensity 
mean) and polydispersity (PDI) and the distribution results. Peaks display the size and 
percentage by either intensity, number for up to three peaks within the results. The 
demonstration of one peak of the distribution in some dispersants, coupled with small 
PDI, is called monomodal or monodisperse. The Z-average is used to compare samples 
dissolved in the same dispersant when polydispersity (PDI) is < 0.5. However for broader 
distributions, with high PDI > 0.5, the distribution graph and analysis and not Z-average 
should be used to determine the size. Zeta potential results are represented in a graph with 
statistics including the mean and standard deviation. Samples were diluted to: 0.01- 0.05 
mg/ml in a total volume of 1 ml in PBS for Zeta measurements. Cell type was chosen as 
disposable polystyrene cuvettes and folded capillary cells for measuring size and zeta 
respectively.  
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Results 
MALDI/TOF, Matrix Assisted Laser Desorption/Ionization Time of Flight Mass 
Spectroscopy. The mass-spectrometric peaks generated, and the most abundant fragment 
at m/z 720 for C60 derivatives (C60OHx and C3) (Figures 30, 31 & 32). The mass spectra 
of fullerenol contain peaks m/z: 720 (C60+), 721 (C60H+), 722 (C60H2+), 737 (C60(OH)+) 
(Figures 31 & 32), other minor peaks can be detected which are attributed to 
oxyfullerenols and sodium salts. The most abundant peak for C70 fullerene derivatives is 
at m/z 840 (Figures 31 & 32). The parent ion is missing from the spectra for all fullerene 
derivatives, indicating changes in the structure of molecules in solution or, more likely, upon 
ionization.  
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Figure 30. MALDI/TOF spectrum shows the most abundant peak for the analysis of C3 is 
720 m/z, fullerane C60H2 was detected at 722 m/z, the presence of fulleranes in C60 mass 
has been detected before. 
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Figure 31. MALDI/TOF spectrum shows the purity of hydroxylated fullerenes (C70OHx and C60OHx). The C70/C60 
ratio in C70OHx is almost 50:50, while the abundant peak at 720 m/z in C60OHx reflects their purity from C70. 
Fullerane C60H2 was detected at 722 m/z; the presence of fulleranes in C 60 mass has been detected before. 
Figure 32. MALDI/TOF spectrum shows the purity of fullerene derivatives (TGA, C70OHx and C60OHx). The C70/C60 
ratio in C70OHx is almost 50:50, while the abundant peak at 720 m/z in C60OHx reflects their purity of C70. Fullerane 
C60H2 was detected at 722 m/z, the presence of fulleranes in C60 mass has been detected before. 
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Optical Spectroscopy. The electron spectrum of fullerene derivatives has no observable 
typical absorption bands. While both C60 and C70 derivatives absorb at 280-330 nm, C70 
derivatives have distinct absorption peaks at ~468-500 nm while fullerenol absorption is 
featureless above 300 nm (Figure 33). The absorption of TTA in water is much higher 
than on other solvents (PBS or DMEM) (Figure 34), indicating its high solubility in 
water. TGA has better solubility in DMEM than TTA (Figure 35). 
Figure 33. Optical absorption spectra of fullerene derivatives in PBS (C60OHx, C3, TGA 
and TTA). The difference in spectra can be used to detect heterogeneity in fullerene 
solution, and C70 contamination in C60 samples. Absorption at 468-500 nm is a feature of 
C70 content in solution. 
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Figure 34. Optical absorption spectra of TTA in different solvents (Water, DMEM and 
PBS). These spectra illustrate the difference in optical density in different solvents, the 
difference can be used to assess the solubility of the sample. Absorption of TTA in 
different solvents is shown in a descending order: water (1) > PBS (0.5) > DMEM (0.49). 
Absorption at 468-500 nm is a feature of C70 content in solution. 
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Figure 35. Absorbance spectra of TGA in different solvents (Water, DMEM and PBS). 
These spectra illustrate the difference in optical density in different solvents. Absorption 
of TGA in different solvents is shown in a descending order; water (0.71) > DMEM 
(0.64)> PBS (0.4). Absorption at 468-500 nm is a feature of C70 content in solution. 
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Figure 36. Absorbance spectra of C3 in different solvents (Water, DMEM and PBS). 
These spectra illustrate the difference in optical density in different solvents. Absorption 
of C3 in different solvents is shown in a descending order; water (0.88) > DMEM (0.69) 
> PBS (0.59). 
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Figure 37. Absorbance spectra of C60OHx in different solvents (Water, DMEM and PBS). 
These spectra illustrate the difference in optical density in different solvents. Absorption 
of C60OHx in different solvents is shown in a descending order; water (0.91) > DMEM 
(0.81) > PBS (0.53). 
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Figure 38 shows that fullerene derivatives have different absorption bands in the 
UV region, indicating the differences in electronic structure. C3 has a highly intense 
absorption and sharp peaks in UV region at 270 nm and a shoulder at 235 nm. However 
C60OHx and ALM showed much lower absorption, whereas C60OHx has the lowest 
intense absorption (fullerol has no absorption bands in UV region). Although C3 and 
C60OHx both have the same core C60 they showed different absorption patterns, 
indicating different behavior in solution and probably different electrochemical structure.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. UV/Vis absorbance spectra of C60OHx, C3 and ALM dissolved in PBS. 
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Zeta potential and Zeta size. The zeta potential graphs for the particles are shown in 
figures (39, 41, 43 & 45). The zeta-potential readings show that all of the fullerene 
particles are negatively charged under the assay conditions, probably due to the presence 
of ionizable OH and COOH groups.  The distribution curves of the particle size of TTA, 
TGA, C3 and C70OHx are shown in figures (40, 42, 44 & 46), the x axis represents 
diameter (nm) while y axis shows the relative intensity of the scattered light. All of 
fullerenes form aggregates in solution (polydisperse distribution) indicated by high to 
moderate PDI values (broad monomodal distribution or the presence of multiple peaks 
within a distribution, heterogeneous distribution of particles) (Table 2). The mean 
diameter of fullerenes in this study ranges from 54.6 nm (C3) to 145 nm (TGA). Most of 
the fullerenes are low charged particles <-30 mV except TGA having a high zeta 
potential, which indicates electrically stabilized colloids, however all fullerenes exhibit a 
tendency to aggregate in solution regardless of zeta potential values.  Fullerenes were 
sonicated in a water bath sonicator for 30 minutes to deagglomerate and disperse the 
particles; however the size of aggregates did not become smaller (Table 2). A previous 
study showed an average size of 268 nm of fullerenol in water [159]. 
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Table 2. Zeta potential values (mV) and average size and size distribution (nm) of 
fullerene derivatives. 
 
Sample Zeta 
(mV) 
Size (nm) Size (nm) after 30 minutes 
sonication  
TTA -2.23  Z-Average= 
119.3, PDI= 0.17 
Z-Average= 112.8, PDI= 
0.192 
 
TGA -39.1  Z-Average= 
145, PDI= 0.427 
Z-Average= 273.6, PDI= 
0.318 
C3 -1.27 54.65 (94.6%) and 
0.781 (5.4%), high 
PDI 
117.2 (100%), high PDI 
 
C70OHX -17.8 92.81 (94.8%), 
6.551 (5.4%), high 
PDI 
36.06 (100%), high PDI 
 
C60OHX - Z-Average= 
100 
- 
ALM - Z-Average= 
120 
- 
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Figure 39. ZETA potential of TTA was -2.23 mV. 
Figure 40. SIZE distribution of TTA. The average size was 119.3 nm. 
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Figure 41. ZETA potential of TGA. The average zeta potential was -39.1 mV. 
Figure 42. SIZE distribution of TGA. Z- average size= 145 nm (Broad size distribution). 
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Figure 43. ZETA potential of C3 was -1.27 mV. 
Figure 44. SIZE distribution of C3. 
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Figure 45. ZETA potential of C70OHx was -17.8 mV. 
Figure 46. SIZE distribution of C70OHx. 
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CHAPTER V 
 
CONCLUSION AND FUTURE STUDIES 
 
 
The mechanism of antioxidant activity of fullerene derivatives was investigated 
for the first time (to our knowledge) using a non cellular assay, FRAP assay. The results 
showed that different fullerene derivatives (C60OHx, C3, TTA and TGA) did not act as 
antioxidants by donating electrons, compared to primary antioxidant such as Vitamin C, 
however their free radical scavenging activity was detected using EPR spectroscopy 
(Electron paramagnetic resonance), which demonstrated the radical scavenging ability of 
fullerenes C3 is similar to that of vitamin C. The previous results of both assays (FRAP 
and EPR) brings a new dimension to the definition of antioxidant and emphasis the 
distinction between antioxidant and antiradical activity of fullerene derivatives. We 
proposed a redox cycle of fullerenes similar to thioredoxin, showing that the reduced 
form of fullerene can acts as an actual reducing agent by donating its electron to 
neutralize ROS. This conclusion is very original and supports the identification of 
fullerenes as selective prooxidant toward ROS but not towards biological 
macromolecules. 
Evaluating fullerenes activity in regard to primary antioxidants was considered 
very critical in drawing our conclusion regarding their activity. Based on this context, the 
radical quenching ability of fullerenes C3 was less efficient than that of vitamin C as 
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shown by EPR spectroscopy results, this is similar to previous documented result 
indicating the less scavenging activity of fullerenes compared to natural enzymatic 
scavenging system, implying the effect of the experimental conditions (e.g. ambient light, 
storage) on their reaction. 
The exposure of cells to either fullerenol or C3 significantly suppressed functional 
NF-κB-driven gene expression in our model. By visualizing the nuclear translocation of 
exogenous NF-κB in cells stimulated with PMA and incubated with fullerenes, along 
with Western blot analysis, we concluded that fullerenes do not inhibit the cytoplasmic 
events of the NF-κB activation pathway. Indeed, they more likely inhibit closer to the 
downstream DNA binding step in the NF-κB pathway.  This was revealed by monitoring 
the expression of an NF-κB targeted gene, detected by measuring PMA stimulated NF-
κB gene expression in cells transfected with a NF-κB binding sequence vector, followed 
by fullerene treatment. 
It is not clear how fullerenes inhibit NF-κB binding to DNA, but by considering 
the redox environment for NF-κB activity which is mediated by thioredoxin (Trx, a redox 
regulator of NF-κB which is translocated to the nucleus in response to PMA inducing 
NF-κB activation), fullerenes might inhibit the reducing enzyme (Trx reductase) resulting 
in an inhibition of NF-κB reduction and subsequently prevent its DNA binding. The 
previous prediction is based on our established knowledge about the role of Trx in 
reducing NF-κB in order to bind to DNA, and in relation to previous studies that 
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demonstrated the ability of fullerenes to bind to HIV-1 protease, showing their potential 
to act as enzyme inhibitors.  
Based on the cytotoxicity tests conducted in this study, exposure to fullerene 
derivatives for 24 hours and up to 100 µM concentration produced negligible toxicity 
(detected by cell proliferation tests), moreover they did not produce ROS in cells.  
However fullerenes derivatives caused a reduction in mitochondrial membrane 
potential. This effect might be cell type specific and or reversible over time, implying the 
need to test their effect on other cells. This affect does not seem to lead to reduced cell 
viability, based on our results from cell proliferation assays, therefore we conclude that at 
least in the short term, these fullerenes may be safe for use in biological system. 
However, the water soluble fullerenes did not demonstrate potent ROS antioxidant 
activity against oxidation induced by TBHP (product of lipid peroxidation).   
There is a considerable challenge in studying the physical and chemical properties 
of water soluble fullerenes. Fullerenes derivatives with multiple moieties are often a 
mixture of many compounds. The high cost and low availability of fullerenes necessitates 
working on a very small scale. The tendency to form aggregates in aqueous media with a 
broad range of diameters is a general limitation for the elucidation and prediction of their 
activities. Because the behavior of fullerenes in solution is complicated, extensive studies 
are needed to investigate their electronic properties in solution in order to be able to 
determine their biological properties according to the surrounding biological 
environment.  
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Overall, this study contributes to the development of pharmacological uses of 
water soluble fullerenes, specifically as anti-inflammatory drugs. This has been 
confirmed (Chapter III) by showing their ability to modulate the activity of the redox 
transcription factor NF-κB. Based on our model, the ability to inhibit NF-κB activation 
pathway is most likely due to a direct or indirect action in the nucleus penultimate to 
DNA binding, since the active fullerene inhibitors of NF-κB fail to block its translocation 
into the nucleus. No inhibition of NF-κB cytoplasmic steps of the pathway was reported 
in this study.  
 
Future Studies 
This study highlights the need to conduct a combination of experimental and 
computational studies to confirm our results and to further enhance our understanding of 
the interactions of fullerene derivatives with the NF-κB activation pathway; 
• Real time PCR (Polymerase Chain Reaction) and proteomics approaches can be 
used to present quantitative measurements of NF-κB activity stimulated by PMA 
under the influence of fullerene derivatives, by assessing the changes in gene 
expression of target genes. It is important to test the molecular events involved of 
the interaction of fullerene derivatives with NF-κB pathway.  
• Other cellular and non-cellular antioxidant tests can be conducted such as: oxygen 
radical absorbance capacity (ORAC) assay, superoxide dismutase (SOD) assay, 
thioredoxin, thioredoxin reductase and catalase activity. 
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• Conduction of a more relevant system involving the use of human cells coupled 
with the detection of the endogenous NF-κB level under the influence of water 
soluble fullerenes.   
• Computational modeling and simulation methods to study the effect of fullerene 
derivatives on the redox structure of NF-κB and the bound conformation of NF-
κB with IκB inhibitor and DNA. 
• Quantum mechanics calculation studies to detect the variation of the electronic 
structure among different fullerene derivatives and under the influence of the 
biological environment.
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APPENDIX A 
 
EPR AND FRAP ASSAYS 
 
 
An electron paramagnetic resonance EPR is often called electron spin resonance 
ESR, it is analogous to nuclear magnetic resonance spectroscopy NMR but instead of the 
measurement of the nuclear transition, EPR is specific for the detection of unpaired 
electron of chemical species such as free radicals and transition metal ions. EPR 
spectroscopy detects the unpaired electron in an applied magnetic field and is sensitive to 
reaction condition of the unpaired electron.  
EPR machine consists of a microwave radiation source known as klystron which 
is a stable vacuum tube, the majority of EPR works at 9.5 GHz, the sample is placed in a 
cavity where it being subjected to a microwave radiation, the weak signal is amplified by 
an amplifier, absorption lines are detected by a detector when separation of energy level 
is equal to the frequency of the incident microwave photons. EPR spectrometer measures 
the absorption of electromagnetic radiation and by using a phase sensitive detector the 
absorption spectrum is converted to its first derivative in the spectrum. EPR spectrum 
results by applying a constant frequency of radiation and varying the magnetic field 
which is represented on the axis of EPR spectrum using the unit gauss (G). The center of 
the EPR signal at zero corresponds to the absorption peak of the absorption spectrum 
(Figure 4).  
EPR spectroscopy is based on an intrinsic spin property of an electron that gives 
rise to the magnetic moment of the electron. S is the spin quantum number, and under the 
application of a magnetic field B0, two spin states of electron, MS, results with different 
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energies or what is called Zeeman effect. The unpaired electron has either parallel 
orientation at the lower energy level, the alignment of the electron magnetic moment with 
the magnetic field represented by MS= -1/2, or antiparallel orientation at the higher 
energy level, the  alignment of the electron magnetic moment against the magnetic field 
represented by MS= +1/2. The energy status of the unpaired electron is represented by the 
following equation; 
 
E = ±1/ 2gβB0 
 
Where g (g-factor) equals ̴ 2.0, β = the Bohr magneto, and B0 is the applied 
magnetic field. For measuring the separation between two spin levels of energy, the 
frequency of microwave irradiation is typically held constant while sweeping the external 
magnetic field. The absorption spectrum results from the transition of an electron from 
the lower state to the higher state (Figure 47. A). The spectroscopy is represented with 
different line shapes and characteristics depending on different factors including the local 
environment of the unpaired electron.
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Figure 47. Generation of EPR spectra.
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Because of the hyperfine interaction which is the interaction between the electron and the 
nucleus. The electron is under the effect of the magnetic field of the applied field and of 
the nucleus causing the Zeeman level to split as a result of hyperfine splitting by the 
value of the nuclear spin quantum number. So the equation is extended further as a result 
of hyperfine interaction, this gives information about the identity and number of nuclei 
and their distance from the unpaired electron. 
 
E = ±1/ 2gβB + aMSMI 
where a is the hyperfine coupling constant, the distance between the centers of 
two signals and MI is the nuclear spin quantum number for the neighboring nucleus. EPR 
spectrum of the free electron changes and split additionally. The nuclear spin and the 
number of lines in the spectrum is determined by 2NI+1, N= number of equivalent nuclei 
interacting and I is the spin, so for a single nucleus with I = ½ will split each energy level 
into two, giving 2 absorption lines (representing two transitions) for one nucleus 
interaction (Figure 47. B). Certain atomic nuclei have certain values of I but the common 
spin is 1/2. The determination of the relative intensities of lines in the spectra depends on 
the number of interacting nuclei. In a case of multiple nuclei interacting with a spin ½, 
the intensities follow binomial distribution.                                                                            
The enzyme/substrate system xanthine/xanthine oxidase was used to determine 
the ROS generation by fullerene derivatives. As most of radical species are difficult to 
detect because of their short life span, DMPO (5,5-dimethyl-1-pyrolline-N-oxide) spin 
trapping reagent is used for radicals detection by forming a persistent aminoxyl spin 
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adduct which have longer life-span. Xanthine oxidase (XO) oxidizes xanthine to uric acid 
[160]. In the presence of spin trapping agent DMPO, DMPO-·OOH adduct formed and the 
detection of this adduct corresponds to superoxide production (Figure 12).  
Hydroxyl adduct DMPO-·OH which originates from hyperfine intereaction of an 
electron spin with a 15N nucleus spin and a 1H nucleus spin with similar coupling results 
in the formation of 1:2:2:1 quartet peaks indicating hydroxyl adduct formation, while the 
hyperfine interaction results in different coupling in superoxide addut DMPO-·OOH 
represented by a different spectrum intensity (Figure 12). Because DETAPAC 
(diethylenetriaminepentaacetic acid) inhibits the formation of hydroxyl adduct DMPO-
·OH [161], it is used to verify the detection of superoxide adducts rather than hydroxyl 
ones.  
The use of 40 µM concentration of different fullerene derivatives did not result in 
reducing radical signal as demosntrated by EPR spectra in figures: 48, 49, 50, 51 & 52. 
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Figure 48. EPR spectra of DMPO-·OOH (Hydroxyl adduct) generated by the 
decomposition of superoxide adduct from xanthine/xanthine oxidase in the presence of 
DMPO only in PBS as the control (A), with the addition of 40 µM of TTA (B) and TGA 
(C) fullerenes derivatives. 
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Figure 49. EPR spectra of DMPO-·OOH (Hydroxyl adduct) generated by the 
decomposition of superoxide adduct from xanthine/xanthine oxidase in the presence of 
DMPO only in PBS as the control (A), with the addition of 40 µM of C3 (B) and C60OHx 
(C) fullerene derivatives. 
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Figure 50. EPR spectra of DMPO-·OH (superoxide adduct) generated from 
xanthine/xanthine oxidase in the presence of 1mM DETAPAC and DMPO in PBS as the 
control (A) and in the presence of 40 µM NAC (B) and 10 mM NAC (C). 
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Figure 51. EPR spectra of DMPO-·OH (superoxide adduct) generated from 
xanthine/xanthine oxidase in the presence of 1mM DETAPAC and DMPO in PBS as the 
control (A) and in the presence of 40 µM of TTA (B) and TGA (C) fullerenes derivatives.  
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Figure 52. EPR spectra of DMPO-·OH (superoxide adduct) generated from 
xanthine/xanthine oxidase in the presence of 1mM DETAPAC and DMPO in PBS as the 
control (A) and in the presence of 40 µM of C60OHx (B).  
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Table 3. EPR reaction mixtures of hydroxyl generation; volumes and concentrations 
 
Reagent, stock solution Concentration 
required 
Volume (µl) 
Control C60OHx 
(872.7 
µM) 
C3 
(784 
µM) 
TGA 
(784 
µM) 
TTA 
(538 
µM) 
PBS, 0.1 M (pH 7.4)   8.75  8.635 7.48 7.47 6.9 
Xanthine solution in PBS   
(1 mM)  
0.5 mM 12.5  12.5  12.5 12.5 12.5 
DMPO, 1 M in PBS 100 mM 2.5  2.5  2.5  2.5  2.5  
Xanthine oxidase                  
(1 units/ml) 
0.05 units/ml 1.25  1.25  1.25  1.25 1.25  
Water soluble fullerenes 40 µM 0.0 0.115 1.27 1.275 1.858 
Total volume reaction* 25 µl 
* The total volume was set to 35 µl for some reactions of EPR spectroscopy 
 
 
Table 4. EPR reaction mixtures of superoxide generation: volumes and concentrations  
 
Reagent, stock solution Concentration 
required 
Volume (µl) 
Control C60OHx 
(872.7 
µM) 
C3 
(784 
µM) 
TGA 
(784 
µM) 
TTA 
(538 
µM) 
PBS, 0.1 M (pH 7.4)  8.75  6.635 5.48 5.47 4.9 
Xanthine solution in PBS          
(1 mM)  
0.5 mM 12.5  12.5  12.5 12.5 12.5 
DMPO, 1 M in PBS 100 mM 2.5  2.5  2.5  2.5  2.5  
Xanthine oxidase                       
(1 units/ml) 
0.05 units/ml 1.25  1.25  1.25  1.25 1.25  
DETAPAC in PBS (12.5 M) 1mM 2.0 2.0 2.0 2.0 2.0 
Water soluble fullerenes 40 µM 0.0 0.115 1.27 1.275 1.858 
Total volume reaction* 25 µl 
* The total volume was set to 35 µl for some reactions of EPR spectroscopy 
 
 
Preparation of Fullerenes: 
The concentration of stock solution of water soluble fullerenes was 1 mg/ml.  
Molecular weight for hydroxylated fullerenes was calculated based on predicting the 
number of OH group, in case of C60 hydroxylated fullerenes, (C60-OH LnW-0564, C- 
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nanomaterials) with 25 OH groups, the molecular weight ≈ 1145.8312 g/mol. Thus the 
molarity is; 
M= (0.001 g)/(1145.8312 g/mole) /(.001 L) = 8.727 x 10-4 M 
FRAP of Fullerenes: 
Figure 53. FRAP assay result showing the color change in a plate. Vitamin C turns 
yellow to blue as a result of reduction of ferric to ferrous, while TTA, TGA and C70OHx 
did not turn the color into blue indicating that there is no reduction activity occurred.
TTA  TGA   TGA    C70OHx  Vitamin C  FRAP 
reagent 
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APPENDIX B 
 
CELL CULTURE AND CYTOTOXICITY OF FULLERENE DERIVATIVES 
 
 
MDCK Cell culture and passaging 
Madin Darby Canine Kidney, MDCK cells were purchased from American Type 
Cell Culture ATCC (Catalog No. CCL-34, CCL-34). MDCK cells are epithelial cells 
(Figure 54) obtained from kidney tissue from Canis familiaris (adult female). Common 
property of MDCK is the exhibition of high transfection efficiency, so it useful for 
studying the expression of exogenous genes and virus propagation.  
MDCK cells were grown in Minimum Essential Medium (MEM) or Dulbecco’s 
Modification of Eagle’s Medium, DMEM, 1X (4.5 g/L glucose & sodium pyruvate 
without L-glutamine & phenol red) (catalogue no. 17-205-CV, Cellgro, Mediatech, Inc, 
Manassas, VA 20109), this media was supplemented with 2 mM of L-Glutamine 200mM 
(100x) solution (Hyclone), 0.1 mM non-essential amino acid solution 100x (Sigma 
M7145) and 10% Fetal Bovine Serum. Cell culture was maintained using aseptic 
technique and without the use of antibiotics. 
Cells were routinely passaged when cell confluence is 80% (mid log phase) and 
subcultured every 3 days (72 hours ± 6 hours) at a seeding density of 5 x 104 to 1 x 105 
cells/cm2 in 25 cm2 vent cap T- flasks (Corning), total volume of media was 5 mL per 
flask . Cells were split at a ratio of 1:50 or higher ratio 1:20 because they were growing at 
a fast rate, therefor the low split ratio is to keep the same amount of confluence. Cells 
were incubated at 37 °C ± 3 °C and 5% CO2  in a humidified environment. Cell counts 
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were determined by counting technique using TC10 automated cell counter (Bio-Rad) 
and cell dilution was typically 1:1 in 0.04% Trypan Blue.  
During the course of this work, different cell batches of the same cell line were 
frozen and kept at liquid nitrogen. For cryopreservation; cells were diluted to get a 
concentration of 1.0 x 106 cells/ ml in cold mixture of 90% DMEM+10% DMSO. Cells 
were transferred to refrigerator for 1-2 hours followed by overnight incubation at -80 °C 
and eventually stored in liquid nitrogen. 
Frozen cells were recovered by placing them immediately in 37 °C water bath to 
rapidly thaw the cells (2 minutes). After spraying with 70% ethanol and then wiping with 
clean paper, the vial content was transferred to 15 ml tube with culture media (2- 4 ml). 
Centrifugation was done at 2000 g (125 xg) for 10 minutes. The supernatant was 
discarded and the pellet was suspended in 1 ml of warm medium that was placed in the 
incubator for at least 15 minutes. Based on cell count, cells are diluted and the calculated 
volume transferred to a 25 cm2 flask, the total volume is brought to 5 ml cell culture. 
Pipetting was done to mix the cells well. Cells were examined under the microscope and 
after that incubated at 37 °C and 5% CO2.  
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Figure 54. MDCK cells after 24 hours incubation (low density). Cells were incubated in 
DMEM with 2 mM of L-Glutamine, 0.1 mM non-essential amino acid solution and 10% 
Fetal Bovine Serum. Picture taken by EVOS FL microscope (AMG Micro, Bothell, WA, 
USA, at 20× magnification). Cells start in calm shape and then develop their epithelial 
morphology over time. 
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The medium is removed and cells are washed with 2-4 ml of 1X PBS (Phosphate 
Buffer Saline) to remove the residual medium. Cells are then incubated with Trypsin 
EDTA solution (Thermo Fisher Scientific Inc. Catalog no. NC0043665) at 37 °C for 15 
to 21 minutes. When cells are almost completely detached, 1-2 ml of medium is added to 
stop trypsinization and pipetting is done to detach all cells. Cell suspension is transferred 
to falcon 15 ml tube (Falcon™ 15mL conical centrifuge tube) and centrifuged for 7-10 
minutes. After discarding the supernatant, the pellet is suspended with 1 ml of warmed 
medium. Cells are diluted and counted as described previously. 
MDCK cells doubling time was calculated based on the formula; 
 
 
 
 
 
 
 
 T2-T1 time difference between cell numbers 
 
 
The doubling time was found to vary according to initial cell number and time 
difference between initial and final number of cells. Cells used in assays were passaged at 
a regular basis after 2-3 days, when confluency is 80%, however they were passaged after 
4 days for a couple of times. The doubling time was found to be around 22 hours (Figure 
55). 
 
 
  [ log (Final cell number) -  log (Initial cell number)] x 3.32 
 1  ÷   
  [T2  -  T1] 
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Figure 55. MDCK cells were maintained in DMEM for less than 20 passaging. Cell 
counts gradually increased over the course of the study. Cells were passaged every three 
to two days. 
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Cytotoxicity Assays 
The reduction of tetrazolium salt is widely used as indication of metabolic activity 
of cells. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a yellow 
tetrazole) is a very common proliferation assay used for the investigation of the reactivity 
of oxi-reductase enzymes. 
 
 
 
Figure 56. A comment tetrazole used in MTT is the diphenyl-tertrazolium bromide (water 
soluble yellow tetrazole) which turns into insoluble purple formazan upon reduction. 
 
 
Another form of tetrazole is used in MTS cell proliferation one step assay, the 
reagent is composed of solutions of a novel tetrazolium compound [3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] in 
the presence of electron coupling reagent, phenazine methosulfate (PMS). MTS is close 
to MTT but it is one solution instead of two. MTS creates a soluble reaction product, 
thereby eliminating the solubilization step required with MTT. MTS is reduced by certain 
intracellular enzymes into a soluble formazan product that can be detected at absorbance 
at 490-500 nm. Cells were observed by the optical microscope to detect any 
morphological changes after fullerene derivatives treatment.  
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The last cell proliferation and cytotoxicity assay used is Alamar Blue, Resazorin 
(C12H7NO4), also known as Diazoresorcinol or Azoresorcin (Figure 57). One advantage 
of using alamar blue along simplicity and sensitivity is biocompatibility to cells. 
 
 
Figure 57. Resazurin assay or Alamar Blue assay is a cell redox indicator, a non-
fluorescent blue dye, resazurin, is converted to bright red fluorescent resorufin by the 
reduction process of live cells. The resulted fluorescent amount is proportional to number 
of cells. The product is measured quantitatively by measuring the fluorescence (560EX 
nm/590EM nm) or absorbance (570 nm), the amount produced is proportional to the 
number of living cells. 
 
 
However, this fluorometric test is not suitable to our model, the observed false 
results, as shown by figure 58, might be due to interference with carbon nanoparticles 
(fullerene derivatives), or probably due to interference with mitochondrial reductase 
activity considering the contribution of mitochondrial reductase to the reduction of 
Alamar Blue.  
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Figure 58. The colorimetric Alamar Blue proliferation assay was used to test the 
viability of cells incubated with water soluble fullerenes. MDCK cells were seeded at a 
density of 2.0 x 105 cells/ml in 96 well black plates and incubated for 24 hours at 37 °C 
in 5% CO2, cells were incubated for further 24 hours at the absence (control) or 
presence of various concentrations of fullerene derivatives; 1, 10, 40 and 100 µM of 
TGA, TTA and C3 as well as Vitamin C. TBHP was used as positive control. 
Fluorescence was detected at excitation/emission 540/590 nm. The Fluorescence 
values represent the mean of four readings and the corresponding standard errors of the 
means (s.e.m.). 
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APPENDIX C 
PROTOCOLS OF PLASMID TRANSFECTION AND WESTERN BLOT 
The plasmid construct 
Figure 59. The approximate plasmid structure of 5KBpHIV-LacZ, five copies of the NF-
κB site (5’-GGGGACTTTCC-3’) were inserted into LTR sequence (Plasm 2.0.4.29, 
plasmid drawing software). The plasmid was extracted from bacterial cells using 
PureYield™ Plasmid Midiprep System from Promega.
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Plasmid sequence and primers (Eurofins MWG Operon (Huntsville, AL 35805) are 
shown below; 
Gene: HIV 3’LTR 
8641 tgtagatctt agccactttt taaaagaaaa ggggggactg gaagggctaa ttcactccca 
8701 acgaagacaa gatatccttg atctgtggat ctaccacaca caaggctact tccctgattg 
8761 gcagaactac acaccagggc caggggtcag atatccactg acctttggat ggtgctacaa 
8821 gctagtacca gttgagccag ataaggtaga agaggccaat aaaggagaga acaccagctt 
8881 gttacaccct gtgagcctgc atggaatgga tgaccctgag agagaagtgt tagagtggag 
8941 gtttgacagc cgcctagcat ttcatcacgt ggcccgagag ctgcatccgg agtacttcaa 
9001 gaactgctga catcgagctt gctacaaggg actttccgct ggggactttc cagggaggcg 
9061 tggcctgggc gggactgggg agtggcgagc cctcagatgc tgcatataag cagctgcttt 
9121 ttgcctgtac tgggtctctc tggttagacc agatttgagc ctgggagctc tctggctaac 
9181 tagggaaccc actgcttaag cctcaataaa gcttgccttg agtgcttca 
Sequence 
TGTAGATCTT AGCCACTTTT TAAAAGAAAA GGGGGGACTG GAAGGGCTAA 
TTCACTCCCA ACGAAGACAA GATATCCTTG ATCTGTGGAT CTACCACACA 
CAAGGCTACT TCCCTGATTG GCAGAACTAC ACACCAGGGC CAGGGGTCAG 
ATATCCACTG ACCTTTGGAT GGTGCTACAA GCTAGTACCA GTTGAGCCAG 
ATAAGGTAGA AGAGGCCAAT AAAGGAGAGA ACACCAGCTT GTTACACCCT 
GTGAGCCTGC ATGGAATGGA TGACCCTGAG AGAGAAGTGT TAGAGTGGAG 
GTTTGACAGC CGCCTAGCAT TTCATCACGT GGCCCGAGAG CTGCATCCGG 
AGTACTTCAA GAACTGCTGA 
Forward: tgtggatctaccacacacaaggct 
Reverse: Accagagagacccagtacag 
FORWARD 
NNNNNNNNNNNNNNNNNNNNNNNNNCNNNCCNNNNNCNGGAGTCAGATATCCACT
GACCTTTGGATGGTGCTACAAGCTAGTACCAGTTGAGCCAGATAAGGTAGAAGAGG
CCAATAAAGGAGAGAACACCAGCTTGTTACACCCTGTGAGCCTGCATGGAATGGATG
ACCCTGAGAGAGAAGTGTTAGAGTGGAGGTTTGACAGCCGCCTAGCATTTCATCACG
TGGCCCGAGAGCTGCATCCGGAGTACAAGGGACTTTCCGCTGGGGACTTTCCGCTGG
GACTTTCCGCTGGGGGACTTCCGCTGGGGGACTTTCCAGGGAGGCGTGGCCTGGGCG
GGACTGGGGAGTGGCGAGCCCTCAGATGCTGCATATAAGCAGCTGCTTTTTGCCTGT
ACTGGGTCTCTCTGGTTAGACCAGATCTGAGCCTGGGAGCTCTCTGGCTAGCTAGGG
AACCCACTGCTTAAGCCTCAATAAAGCTTGGGATCTCTATAATCTCGCGCAACCTATT
TTCCCCTCGAACACTTTTTAAGCCGTAGATAAACAGGCTGGGACACTTCACATGAGC
GAAAAATACATCGTCACCTGGGACATGTTGCAGATCCATGCACGTAAACTCGCAAGC
CGACTGATGCCTTCTGAACAATGGAAAGGCATTATTGCCGTAAGCCGTGGCGGTCTG
GTACC 
GGTGGGTGAAGACCAGAAACAGCACCTCGAACTGAGCCGCGATATTGCCCAGCGTTT
CAACGCGCTGTATGGCGAGATCGATCCCGTCGTTTTACAACGTCGTGACTGGGAAAA
CCCTGGNGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGT
AATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCANCCTGAATGGC
NAATGNNGCTTTGCCTGGTTNNCGGNACCAGAAGCGGTGCCGGAAANNCTGGCTGG
NNNNCGATCNTCCTGAAGCCNATACTGTCGNNCGTCCCCNTCAAACTGGCAGATGCA
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CGGNTTACGATGNNNCCCANTCTACNACCAAACGTGAACCTANCCCNTTNNNGNNN
ANCCGCCCGTTTNNNNANCNGNNNNATCCNACGGNNNNNNNCNCCTCNNNTNNNNG
NTGANGNANNNGGGCNNNNNNNANGNNNNNNCNNGNANTNNNTTNNNNNGNNNNT
ANNNNNNGNGNNN 
Reverse: 
NNNNNNNNNNNNNNNNNNNNGNNNCATCTGANGGCTCGCCACTCCCCAGTCCCGCC
CAGGCCACGCCTCCCTGGAAAGTCCCCCAGCGGAAGTCCCCCAGCGGAAAGTCCCA
GCGGAAAGTCCCCAGCGGAAAGTCCCTTGTACTCCGGATGCAGCTCTCGGGCCACGT
GATGAAATGCTAGGCGGCTGTCAAACCTCCACTCTAACACTTCTCTCTCAGGGTCATC
CATTCCATGCAGGCTCACAGGGTGTAACAAGCTGGTGTTCTCTCCTTTATTGGCCTCT
TCTACCTTATCTGGCTCAACTGGTACTAGCTTGTAGCACCATCCAAAGGTCAGTGGAT
ATCTGACTCCTGGCCCTGGTGTGTAGTTCTGCTAATCAGGGAAGTAGCCTTGTGTGTG
GTAGATCCACAGATCAAGGATATCTTGTCTTCTTTGGGAGTGAATTAGCCCTTCCAGT
CCCCCCTTTTCTTTTAAAAAGTGGCTAAGATCTACAGCTGCCTTGTAAGTCATTGGTC
TTAAAGGTACCTGAGGTGTGACTGGAAAACCCACCTCCTCCTCCTCTTGTGCTTCTAG
CCAGGCACAAGCAGCATTGGTAGCTGCTGTATTGCTACTTGTGATTGCTCCATGTTTT
TCCAGGTCTCGAGGATACTGGCTTAACTATGCGGCATCAGAGCAGATTGTACTGAGA
GTGCACCATATGCGGTGTGAAATACCGCACAGATGCGTAAGGAGAAAATACCGCAT
CAGGCGCTCTTCCGCTTCCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCG
GCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGG
ATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA
AAAGGCCGCGTTGCTGGCGTTTTTCCATANGCTCCGCCCCCTGACGAGCATCACAAA
AATTCGANGCTCAAGTCAGAGGTGGCGAAANCCNACAGGACTNNNAANATNCNAGN
NTTTCCCCNNGAAGCTNCNNNGTGCGNTNNCNGNTCCNACCNNCNCTACNNANNCN
GTCCNCTTTCTCCTTCGGNNCGNGNNGNTTNTNNANNNNNNNACNCTGNAGNNTNN
NCAGTCGGNGNANNNN 
Transfection with 5kB-LacZ plasmid 
To study the effect of water soluble fullerenes on HIV LTR promoter activity and 
potential inhibition, cells were transfected with pHIV.5kB-LacZ using lipofectamine-
2000, in 96 well plates, with each well seeded with 2.0 ×104 cells/well and 0.2 μg (0.2 
μg/well) of 5kB-LacZ plasmid DNA. Cells were grown in MEM immediately after 
transfection for 48 hours 
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1. MDCK cells with 50-70% confluency were tryptinized at 37 °C and 5% CO2 for 
around 25 minutes, then they were resuspended in medium (MEM+10%) and 
seeded onto wells as a density of 2.0 x 104 cells/well. 
2. Cells were incubated at 37 °C and 5% CO2 for 24 hours,  
3. Transfection was done using 0.22 µg DNA and 0.5 µl lipofectamine 2000 for 
each well, ratio of (1:2.3), since there are 21 wells for transfection; lipofectamine 
(11 μl) was diluted in 110 μl OptiMEM medium and incubated for 5 minutes at 
RT, then 4.78 µl of 5kB-LacZ (920 μg/ml) was diluted in 110 μl OptiMEM 
medium.  
4. The two mixtures (DNA and lipofectamine 2000) were mixed together and 
allowed to form for 20 minutes.  
5. The plasmid DNA- Lipofectamine™ 2000 complexes 10 μl were added directly 
to each well of the plates containing cells and mixed gently 
6. Different concentrations of fullerenes (8.6 x 10-6M and 7.8 x 10-7M) were added 
to cells after one hour of transfection.   
7. PMA was added to activate the LTR, a concentration of 300 nM was added 3 
hours after transfection (2 hours after the addition of fullerenes). 
 
Measurement of NF-κΒ inhibition in 5KBpHIVLacZ transfected cells by β- 
galactosidase reporter gene activity  
Enhanced β-Galactosidase Assay Kit (genlatis A10100K) uses the chromogenic 
substrate chlorophenol red-β-D-galactopyranoside (CPRG). The expression of β- 
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galactosidase is measured by its cleavage of CPRG subsequently resulting in production 
of chlorophenol red, which is measured by colorimetric assay using a standard 96 well 
plate reader. The assay was done following the manufacture instructions and absorbance 
was read at 575 nm with a microtiter spectrophotometer. 
• After 48 hours of incubation, cells were treated according to Enhanced β-
Galactosidase Assay Kit (CPRG) protocols as following: 
a. 1X Lysis buffer was added (volume; 50 µl) to each well, and the plate was 
incubated for 12 minutes at room temperature by swirling it slowly several 
times to ensure complete lysis. The cells were observed under a 
microscope to confirm cells lysis. 
b. A quick freeze/thaw cycle (freeze 25 minutes at -78°C and thaw at room 
temperature) of the plate was done to obtain a good lysis.  
c. After thawing the plate of lysed cells at room temperature, 50 μl of 
standard dilution buffer was added to each of the wells of a 96-well plate 
except the control wells, which are set aside for standard curve. 
d. The standards were prepared by making a serial dilution of β-galactosidase 
(E.coli) standards using standard dilution buffer: according to the 
manufacture’s instruction. 
• 50 μl of each the standards was added to the control wells of the 
plate - the highest recommended amount of β-galactosidase is 100 
milliunits (100,000~200,000 pg). Don’t add lysis buffer to the 
standard wells, only β-galactosidase and CPRG. 
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e. The blank was prepared by adding 50 μl of lysis buffer to a well and 50 μl 
of cell lysate from non-transfected cells (mock-transfected cells) to a well 
to control endogenous β-galactosidase activity. 
f. 100 μl of 1X CPRG substrate solution was added to each well and the 
plate was incubated at room temperature until the dark red color 
developed (from approximately 1- 3 hours depending on the cell 
confluency). The standards were measured immediately after loading (10 
min). 
g. The absorbance was read at 575 nm with a microtiter spectrophotometer.  
h. Quantify β-galactosidase expression based on a linear standard curve 
 
Reagents preparation: 
• 5X lysis buffer was diluted to 1X using distilled deionized water before use. 
Unused 1X Lysis buffer may be stored at 4°C for future use; 
• 10X CPRG stock was diluted to 1X using substrate buffer just before performing 
the colorimetric assay. The unused 1X CPRG was stored at -20°C for future use. 
It is recommend to use 1X CPRG solution only 2 times after a freeze/thaw cycle.  
 
Protocols for gel electrophoresis and western blot 
1. Cells were seeded at a density of 3 x105 cells/ml per well using 6 well plate 
2. After 24 hours of cell incubation at 37 °C and 5% CO2, cells were treated with 40 
µl C60OHx 
3. Cells were stimulated with 25 µl PMA after 24 hours of incubation with C60OHx. 
149 
  
4. Proteins were extracted using NF-κB extraction kit (NFKB2, Five photon 
biochemical, San Diego, California) following the manufacturer’s instructions. 
5. Sample buffer was prepared by mixing 950 µl of Laemmli Sample buffer (161-
0737) with 50 µl of 2- Mercaptoethanol BME (161-0710). 
6. Protein was diluted with the prepared sample buffer in 1:1 ratio and then samples 
were heated at 95°C for 5 min and thereafter loaded onto SDS-PAGE gels. 
7. Cell lysates were fractionated using precast polyacrylamide gel, 4–20% SDS-
PAGE gel (mini- Protean TGX, Bio-Rad. Cat. 456-1093), this gel is suitable to 
resolve p65 (molecular weight approximately 65kD). Protein samples were loaded 
into each well (30 µl/well). Using sample buffer (Laemmli, dilute 1:1 with 
sample). Precision plus protein standards, dual color, catalogue number 161-0374. 
10 µl was loaded into a well 
8. After loading the gel apparatus with running buffer (standard Tris-glycine running 
buffer, Tris/glycine/SDS, cat. # 161-0732), it was run for 15 minutes at 300 volts 
for approximately 15 minutes).  
9. After SDS-PAGE gel is resolved, proteins were transferred to a nitrocellulose 
membrane (Trans-Blot® Turbo™ Mini Nitrocellulose Transfer Packs, (170-4158) 
using Trans-Blot Turbo kit (Bio-Rad Cat. # 170-4155) which performs semi dry 
blotting within 3 minutes. 
10. After the disassembly of the cassette, the membrane was incubated with a freshly 
made blocking solution (1X PBS + 5% non-fat dry milk) at room temperature 
with shaking.  
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11. The blot was incubated with primary antibody P65 (No. p65Ab, Rab IgG, Lot 388 
, Five photon Biochemicals) at a dilution of 1:400 in PBS-T solution (1X PBS + 
0.05% Tween20) in a total volume 4 ml in a falcon tube 50 ml at room 
temperature with shaking. 
12. The membrane was washed five times with PBS-T (1X PBS containing+ 0.05% 
Tween20) washing for 5 times, with the first wash at 15 minutes and the 
remaining washes each at 5 minute intervals afterwards.  
13. The wash solution was discarded and the membrane was incubated with 
secondary antibody goat anti–rabbit IgG- HRP at a dilution 1:3000 in PBS-T (1X 
PBS containing+ 0.05% Tween20). 
14. The membrane was washed five times with PBS-T (1X PBS containing+ 0.05% 
Tween20) washing for 5 times, with the first wash at 15 minutes and the 
remaining washes each at 5 minute intervals afterwards.  
15. Membrane was washed and NF-κΒ proteins were detected using an enhanced 
chemiluminescence (ECL) reagent, ECL kit, (the detection kit was applied 
following the manufacture’s instruction of mixing reagent A with reagent B), the 
mixture was applied to the membrane for 5 minutes with shaking. Bio-Rad 
ChemiDocTM XRS+ System was used for the detection of chemiluminescence 
controlled by Image Lab™ software. 
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